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Abstract 
 Antisense non-coding transcripts, genes-within-genes, and convergent gene 
pairs are prevalent among eukaryotes. The existence of such transcription units raises 
the question of what happens when RNA polymerase II (RNAPII) molecules collide 
head-to-head. In this study a combination of biochemical and genetic approaches in 
yeast are used to show that polymerases transcribing opposite DNA strands cannot 
bypass each other. RNAPII stops, but does not dissociate upon head-to-head collision in 
vitro, suggesting that opposing polymerases represent insurmountable obstacles for each 
other. Head-to-head collision in vivo also results in RNAPII stopping, and removal of 
collided RNAPII from the DNA template can be achieved via ubiquitylation-directed 
proteolysis. Indeed, in cells lacking efficient RNAPII poly-ubiquitylation, the half-life 
of collided polymerases increases, so that they can be detected between convergent 
genes. These results provide new insight into fundamental mechanisms of gene traffic 
control, and point to an unexplored effect of antisense transcription on gene regulation 
via polymerase collision. 
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Chapter 1. Introduction 
1.1 RNA Polymerase II transcription 
 The central dogma of molecular biology states that the genetic code stored in 
DNA is transcribed to mRNA, which provides a template for translation and protein 
synthesis. In eukaryotes, the protein responsible for transcribing DNA into mRNA is the 
multi-subunit complex RNA polymerase II (RNAPII). Transcription is a highly 
regulated and fundamental biological process, being an end-point of virtually all cell-
signalling pathways. Additionally, deregulation of transcription is responsible for 
numerous diseases, including cancer. 
 Transcription can be divided into three main stages: initiation, elongation and 
termination. Initiation involves the binding of transcriptional activators to enhancers, 
recruitment of general transcription factors and loading of RNAPII onto promoter DNA. 
Following promoter escape, RNAPII enters into the elongation phase, during which 
RNA is produced, prior to termination and dissociation of polymerase from the DNA.  
Extensive regulation occurs at all stages of RNAPII transcription and will be 
covered in more detail in the following sections. The main focus of this introduction 
will be on topics directly relevant to this thesis: RNAPII structure and function, 
transcript elongation and its associated factors, genome organisation and 
transcriptomics. Other aspects of transcription are discussed, albeit in less depth. 
1.1.1 RNAPII structure and function  
 Knowledge of the structure and function of RNAPII is a pre-requisite for a 
comprehensive understanding of transcription, and particularly, transcript elongation. 
Chapter 1 Introduction 
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RNAPII is a 12-subunit heteromeric complex, consisting of Rpb1-12, with a total mass 
in excess of 500 kDa. RNAPII is highly conserved between even distantly related 
eukaryotes, with a primary protein sequence identity of 53% and in excess of 80% 
overall homology (similarity) between Saccharomyces cerevisiae and Homo sapiens 
(Cramer et al., 2001). Remarkably, in complementation studies the expression of 
mammalian RNAPII subunits, Rpb5, 6, 7, 8, 9 and 10 were able to restore viability to 
yeast carrying genetic deletions of the counterpart genes (Shpakovski et al., 1995, 
McKune et al., 1995, Khazak et al., 1995).  
 RNAPII is a DNA-dependent RNA polymerase and so uses DNA as a template 
for the production of complementary RNA. Incoming nucleoside triphosphates (NTPs) 
base-pair to the DNA template strand and via an RNAPII-catalysed condensation 
reaction, the chain is elongated with a concomitant release of inorganic pyrophosphate 
and forward movement of RNAPII (Herbert et al., 2008). Details of this mechanism will 
be discussed later. 
 Although complete RNAPII contains 12 subunits, the population of cellular 
RNAPII is not homogeneous; it also exists as a 10-subunit complex lacking Rpb4 and 
Rpb7, which form an autonomous sub-complex. The association between Rpb4 and 
Rpb7 was confirmed by genetic manipulation in yeast, as rpb4∆ cells yielded only the 
10-subunit RNAPII, lacking Rpb7 (Woychik and Young, 1989, Woychik et al., 1991). 
Dissociation of the Rpb4/7 complex is probably regulatory and may play a role in the 
stress-response. Indeed, in vitro assays have shown that the 10-subunit RNAPII is 
unable to initiate transcription at a promoter, but is catalytically active in a non-specific 
transcription assay, suggesting this is a mechanism by which RNAPII can be made 
initiation-incompetent (Edwards et al., 1991). 
Chapter 1 Introduction 
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 Early attempts at RNAPII crystallisation were marred by the heterogeneity of 
the complex, but upon preparation of highly purified RNAPII from rpb4∆ strains, EM 
structural topography was revealed at 16Å resolution (Darst et al., 1991), followed by a 
5 Å X-ray structure (Fu et al., 1999). Improvements were made in the crystallisation 
process leading to increased resolution (Cramer et al., 2000) and ultimately to a 2.8 Å 
resolution model of free RNAPII (Cramer et al., 2001), as well as a model of an 
RNAPII elongation complex (EC) at 3.3 Å (Gnatt et al., 2001). The studies revealed the 
position of Rpb1 and Rpb2, which form a positively charged active centre cleft spanned 
by the bridge helix, with the smaller subunits distributed around the periphery (Figure 
1.1A). The EC model showed that double-stranded DNA passes into the cleft between 
the upper jaw (composed of Rpb1 and Rpb9) and the lower jaw (Rpb5), with the 
transcription bubble and DNA-RNA hybrid positioned at the active site (Gnatt et al., 
2001). DNA is bent to an angle of approximately 90° as it passes through RNAPII due 
to the presence of the Rpb2 protein wall blocking the back of the cleft. 
 During transcription, it is necessary that the transcription bubble of 
approximately 18 bp, containing an 8-9 nt RNA hybrid, is maintained (Saeki and 
Svejstrup, 2009, Wang et al., 2006, Kireeva et al., 2000). The structure implicates two 
features called “fork loops” in this process (Figure 1.1B). Fork loop 2 of the Rpb2 
subunit is responsible for separating the DNA prior to it reaching the bridge helix, 
whilst fork loop 1 of Rpb1 interacts with, and stabilises, the DNA-RNA hybrid. 
Upstream of the hybrid the DNA rewinds, but the energetically favourable DNA-RNA 
hybrid has to be disrupted to allow this. This is achieved by the rudder and lid of 
RNAPII, with the rudder contacting and stabilising the DNA whilst a phenylalanine  




Figure 1.1 RNAPII elongation complex structure. 
A. (Left) Side-view of RNAPII-EC. (Right) Top-view of RNAPII-EC. DNA TS, NTS and RNA 
are coloured as indicated. RNAPII subunits are coloured as in schematic representation (top). B. 
Detailed structure of RNAPII-nucleic acid interactions, with key structural features labelled. 
See text for details. Reproduced with permission (Kettenberger et al., 2004). 
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residue of the lid acts as a wedge to separate the DNA-RNA hybrid (Westover et al., 
2004b).  
 At the floor of the RNAPII cleft is the active site where NTP addition occurs 
through a two metal-ion mechanism common to all polymerases (Steitz, 1998). A Mg2+ 
cation (metal A) is stably bound by Rpb1 aspartates 481, 483 and 485 and binds the 
RNA 3’ end (Cramer et al., 2001). Metal B is not always stably bound and arrives with 
the NTP, interacting with aspartate 481, 837 and glutamate 836 of Rpb2 (Westover et 
al., 2004a, Cramer et al., 2001). Switch regions 1 and 2 of Rpb1 bind to the DNA 
template “active base” and flip it approximately 90° in a left-handed direction towards 
the pore, a channel present at the bottom of the cleft. This is assisted by the bridge helix, 
over which the template strand runs, which separates the active base from the 
downstream base.  
 Two important sites have been defined in the active centre of RNAPII: the entry 
site (E-site), which NTPs first encounter upon entry through the pore, and the addition 
site (A-site), where catalysis occurs and only NTPs correctly matched to DNA are 
observed (Westover et al., 2004a). An NTP in the A-site causes the trigger loop (Rpb1 
residues between ~1070 and 1100 (Kettenberger et al., 2003)) to swing into position, 
leading to changes in the bridge helix conformation. The interactions between NTPs 
and the bridge helix and trigger loop are extensive. These occur between amino acids 
and the β-phosphate, 2’-OH and 3’-OH, allowing RNAPII to recognise the correct NTP 
for catalysis (Wang et al., 2006). Following catalysis, PPi release leads to a disruption of 
the trigger loop interaction, altered conformation of the bridge helix and a “relaxing” of 
the active site, allowing translocation of the DNA-RNA hybrid. Entry of RNAPII into a 
Chapter 1 Introduction 
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post-translocated state allows the cycle of NTP addition to be repeated (Wang et al., 
2006).  
 Another key element of RNAPII is the Rpb1 clamp, a mobile domain shown to 
occupy two different open states (Cramer et al., 2001), but which enters into a closed 
state when in a complex with DNA and RNA (Gnatt et al., 2001).  Closure of the clamp 
involves movement of some RNAPII residues by up to 30 Å and is implicated in 
RNAPII processivity, as the DNA-RNA hybrid is secured (Gnatt et al., 2001). 
Additionally, it has been suggested that this is the cause of EC stability in high salt 
(Gnatt, 2002, Levin et al., 1987). As mentioned earlier, the switch regions interact with 
the DNA-RNA hybrid, but also with each other. The presence of a DNA-RNA hybrid 
results in switch 3 becoming ordered and movement of switch 2 to prevent steric 
collision; the end-point of these molecular re-arrangements is clamp closure (Gnatt et 
al., 2001). 
 A note-worthy, non-catalytic feature of RNAPII is the Rpb1 carboxy-terminal 
domain (CTD) consisting of 52 heptapeptide repeats of a motif with the consensus 
sequence Y1S2P3T4S5P6S7 in humans, and 26 repeats in yeast (Corden, 1990). The CTD 
is linked flexibly to the RNAPII core close to the RNA exit site (Cramer et al., 2001). 
The CTD can be phosphorylated by various kinases on tyrosine 1 (Tyr1), serine 2 
(Ser2), threonine 4 (Thr4), serine 5 (Ser5) and serine 7 (Ser7) and acts as a platform for 
the recruitment of elongation-associated factors involved in 5’ or 3’ RNA processing 
events (Hirose and Manley, 2000, Proudfoot et al., 2002, Mayer et al., 2012), the details 
of which will be discussed later.  
 In RNAPII structural studies, no protein density was observed for the CTD of 
Rpb1, possibly due to disorder as a result of its flexibility (Cramer et al., 2001). CTD 
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peptides were used to determine the crystal structure of unphosphorylated, Ser5 
phosphorylated and Ser2 phosphorylated CTD (Meinhart and Cramer, 2004). The CTD 
was shown to be a left-handed β-spiral, most compact when unphosphorylated, 
stabilised by Ser2 phosphorylation and opened following Ser5 phosphorylation, thus 
providing a structural basis for the temporal recruitment of elongation-associated factors. 
1.2 Initiation 
 The binding of RNAPII to the promoter region of DNA and its assembly into a 
pre-initiation complex (PIC) was for many years believed to be the principal step at 
which transcription was controlled. Indeed, in many of the early systems used to study 
initiation (such as at GAL4 in S. cerevisiae and the lac operon in E. coli) RNAPII 
recruitment is a limiting factor. Further studies have shown that regulation of 
transcription is a multi-faceted process with myriad other points for regulation, 
including at promoter clearance and during transcript elongation. Nevertheless, the 
process of initiation is highly controlled with many proteins playing a role. 
1.2.1 Formation of the pre-initiation complex 
 The PIC is a complex of multiple proteins that direct the recruitment of RNAPII 
to the promoter and catalyse DNA melting, thus enabling transcription to occur. The 
PIC is made up of general transcription factors (GTFs) in a complex with RNAPII. The 
minimal set of GTFs required to direct basal (non-activated) transcription on a 
nucleosome-free DNA template are: TFIIB, TFIID, TFIIE, TFIIF and TFIIH (Nechaev 
and Adelman, 2011). Formation of the PIC in vivo is highly dynamic and most likely 
occurs in a stepwise manner, however, there is a suggestion that assembly can also 
occur via the single-step recruitment of a pre-assembled RNAPII holoenzyme (McNally 
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et al., 2000, Koh et al., 1998, Wilson et al., 1996, Maldonado et al., 1996, Ossipow et al., 
1995).  
Sequence elements in core promoters direct PIC assembly, ensuring that 
transcription occurs at appropriate positions within the genome (Hahn, 2004, Cosma, 
2002). There are a number of different sequence elements found in core promoters, 
including the TATA element, BRE (TFIIB-recognition element), Inr (initiator element) 
and DPE (downstream promoter element) (Smale and Kadonaga, 2003). These 
sequences are binding sites for proteins of the PIC and serve to correctly orientate 
RNAPII, determining the direction of transcription. Although most promoters contain 
one or more of these elements no particular one is absolutely required to facilitate 
initiation. 
 The TATA element is the most ancient and widely used core promoter element 
in nature (Figure 1.2A). The element has the consensus sequence TATAWAAR with 
the upstream nucleotide at -31 to -30 relative to the transcription start site (TSS) in 
mammals (Carninci et al., 2006, Ponjavic et al., 2006). The TATA DNA is bound by 
the TATA-binding protein (TBP), a saddle-shaped molecule consisting of two imperfect 
repeats. TBP binds to the widened minor groove of the TATA element, unwinding 
DNA approximately one third of a helical turn and bending it by approximately 80 Å 
towards the major groove (Kim et al., 1993b, Kim et al., 1993a). TBP bound to TATA 
DNA represents the initial step in GTF recruitment at this promoter element (Figure 
1.2), with other GTFs being necessary to direct the orientation of TBP binding (Cox et 
al., 1997). 
 The BRE element is bound by TFIIB and is also well-conserved, the archael 
TFB binds a similar sequence, where it is the primary determinant of transcription 
Chapter 1 Introduction 
 22 
orientation (Lagrange et al., 1998, Qureshi and Jackson, 1998, Bell et al., 1999, 
Littlefield et al., 1999). The other two well-characterised elements are Inr and DPE. The 
Inr element is able to bind TBP-associated factors TAF1 and TAF2 (Chalkley and 
Verrijzer, 1999), while the DPE element is in close proximity to TAF6 and TAF9 
(Burke and Kadonaga, 1997). Approximately fourteen TAFs and TBP form a complex 
known as TFIID, which is highly conserved in evolution (Sanders and Weil, 2000). The 
proper function of DPE-based promoters relies on the presence of the Inr element 
because they together co-ordinate TFIID binding (Burke and Kadonaga, 1997). 
 In addition to being a subunit of TFIID, TBP has been found in other 
transcription-related complexes, an interesting one being SAGA, a histone 
acetyltransferase (HAT) complex recruited to upstream activating sequences (UAS). 
TBP directly interacts with the Spt3 subunit of the complex (Laprade et al., 2007, 
Eisenmann et al., 1992, Mohibullah and Hahn, 2008). Indeed, studies have even shown 
that there is a high degree of similarity between the composition of SAGA and TFIID, 
and that these two complexes have a remarkably similar shape (Wu et al., 2004, Leurent 
et al., 2002). In agreement with the two complexes also having similar functions, 
studies using yeast mutants showed that approximately 10% of genes were dependent 
on SAGA rather than TFIID for their transcription, and that highly-inducible genes with 
clear TATA boxes were SAGA-dependent whilst their housekeeping counterparts with 
no recognisable TATA box preferentially recruited TFIID (Basehoar et al., 2004, 
Huisinga and Pugh, 2004). 
 The relative rarity of TATA-based promoters in many higher eukaryotes such as 
Drosophila melanogaster suggests that the method of promoter core recognition is more 
complicated than reductionist models would suggest (Ohler et al., 2002). Drosophila 
Chapter 1 Introduction 
 23 
and human TATA-less promoters have both the Inr and DPE elements, suggesting that 
in this subset of genes the TAFs have a greater functional role than TBP for PIC 
assembly, but TBP probably confers stability owing to protein-protein interactions 
between the GTFs (Smale and Kadonaga, 2003). 
 Following the binding of TFIID or SAGA to the core promoter (Figure 1.2B), 
the next event is likely to be binding of TFIIA or TFIIB, both of which interact 
specifically with TBP and have affinity for the bent promoter DNA (Figure 1.2B) 
(Nikolov et al., 1995, Geiger et al., 1996, Tan et al., 1996).  
 TFIIA is a heterodimer composed of two domains, the C-terminal is responsible 
for the TBP-DNA interaction whilst the N-terminal domain points away from TBP. 
TFIIA has two main functions: it stabilises TBP-DNA binding and promotes TFIID 
binding to DNA by competing with the N-terminal domain of TAF1, which masks the 
TBP DNA-binding surface in free TFIID (Weideman et al., 1997, Kokubo et al., 1998, 
Liu et al., 1998, Sanders et al., 2002). 
 TFIIB has two domains both of which are highly conserved; the N-terminal is a 
zinc-ribbon domain connected via a flexible linker to the C-terminal core domain, 
which binds TBP-DNA. TFIIB has a role in RNAPII recruitment as both domains co-
operatively bind RNAPII with the functional surface of the ribbon domain absolutely 
required for this function (Chen and Hahn, 2003, Pardee et al., 1998, Hahn and Roberts, 
2000). Part of the flexible linker known as the B-finger is positioned in the active centre 
of RNAPII and both biochemical and structural studies have implicated it in 
determination of the TSS (Bushnell et al., 2004, Kostrewa et al., 2009, Liu et al., 2010). 
 The next step in PIC assembly following formation of the TFIID/TBP-TFIIA-
TFIIB sub-complex is likely to be binding of TFIIF, which probably has a role in the 
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correct positioning of RNAPII (Figure 1.2B). TFIIF has been shown to reduce the non-
specific DNA affinity of RNAPII in vitro, consistent with this assertion (Finkelstein et 
al., 1992). The final two GTFs to bind the PIC are TFIIE and TFIIH, which interact 
strongly, and bind the DNA both upstream and downstream of the TSS (Figure 1.2C) 
(Bushnell et al., 1996). RNAPII associates with the GTFs and promoter DNA where the 
conserved heterodimer TFIIE binds to the polymerase jaw and probably has a role in 
regulating jaw conformation and the transition from the closed to the open complex 
(Leuther et al., 1996). Also, TFIIE has the ability to stimulate both the kinase and 
helicase activities of TFIIH (Figure 1.2D) (Lu et al., 1992, Ohkuma and Roeder, 1994). 
 Initiation at most promoters is ATP-dependent and this is due to the final stage, 
which requires TFIIH helicase activity. Low resolution EM of TFIIH has shown it to be 
a ring-shaped complex with two helicase subunits located either side of a prominent 
protrusion (Schultz et al., 2000, Chang and Kornberg, 2000). Studies have shown the 
ATPase activity of the helicase-related TFIIH subunit XPB (Ssl2 in yeast) to be 
essential for DNA strand separation and transition to the open complex (Figure 1.2D) 
(Coin et al., 1999). Recent work in the Hahn laboratory has shown that Ssl2 interacts 
directly with TFIIE and acts as a double-stranded DNA translocase. The fixed position 
of Ssl2, along with the anchoring of upstream DNA by the other GTFs (namely TBP, 
TFIIA and TFIIB), and combined with Ssl2 DNA translocation, leads to right-handed 
rotation of the DNA helix, unwinding and feeding of 15 bp of single-stranded DNA into 
the RNAPII cleft (Figure 1.2D and E) (Kim et al., 2000, Grunberg et al., 2012). 
Additionally, the TFIIH kinase Cdk7 (Kin28 in yeast) is responsible for Ser5 
phosphorylation of the Rpb1-CTD, a key step, which destabilises the interaction 
between RNAPII, Mediator and the PIC, allowing the transition to the next step in  




Figure 1.2 Pre-initiation complex formation and initiation 
A. Promoter DNA with a TATA box indicated. B. TFIID/TBP (green) binds TATA DNA, 
bending it. Next TFIIB (orange), TFIIA (light red) and TFIIF (dark red) bind. C. TFIIE (yellow) 
and TFIIH (grey) bind DNA. Mediator (purple) associated with UAS-bound activators (light 
green) associates with the PIC and RNAPII (blue). D. Mediator stimulates kinase activity of 
TFIIH leading to CTD Ser5 phosphorylation (5P), whilst the Ssl2 translocase opens DNA in an 
ATP-dependent manner (white arrow). E. Single-stranded DNA is fed into the RNAPII active 
site and RNA polymerisation begins. 
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transcription (Figure 1.2D and E) (Lu et al., 1992, Liu et al., 2004, Svejstrup et al., 1997, 
Max et al., 2007).  
1.2.2 The role of additional factors in initiation 
 There are numerous other factors that have a role in initiation, including myriad 
activators and repressors, which bind at promoter distal elements, namely UASs and 
enhancers. However, this section will only focus on a few factors that also play a role in 
general transcription initiation, the first being Mediator. 
 Mediator is a 24-subunit complex first isolated in yeast and shown to be 
essential for activated transcription, whilst also increasing both the efficiency of basal 
transcription and of TFIIH-catalysed CTD phosphorylation (Kim et al., 1994). Mediator 
interacts with un-phosphorylated RNAPII; approximately 40% of it is in a stable 
complex with polymerase (Rani et al., 2004). Mediator has three domains: the head, 
middle and tail, which bind to RNAPII via Rpb3 and Rpb11 (Davis et al., 2002). 
Genome-wide studies have shown Mediator to be present upstream of almost all active, 
and some inactive, genes. This is presumably a result of interactions between Mediator 
and activators bound to upstream regulatory sequences (Andrau et al., 2006, Zhu et al., 
2006). Consistent with this assertion, crosslinking studies have shown that Mediator can 
be recruited to promoters prior to binding of the basal transcription machinery, probably 
due to activator-based recruitment, which could lead to Mediator being transferred to 
the PIC (Bhoite et al., 2001, Bryant and Ptashne, 2003, Cosma et al., 2001). The 
formation of the PIC and order of GTF binding seems to be a highly dynamic process; 
evidence suggests that this is also the case for Mediator, with some in vitro data 
showing that TFIIB, RNAPII and Mediator can be recruited to the promoter co-
operatively (Ranish et al., 1999). Nevertheless, binding of Mediator is a key stage in 
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PIC formation and its stimulation of TFIIH kinase activity could represent a checkpoint 
during initiation, with the resulting CTD phosphorylation leading to a disruption of the 
Mediator-RNAPII interaction (Svejstrup et al., 1997, Max et al., 2007). Mediator 
subsequently stabilises a sub-complex of basal factors that remain behind at the 
promoter following movement of RNAPII into the early elongation phase, and likely 
accelerates the rate of subsequent re-initiation events (Reeves and Hahn, 2003, Esnault 
et al., 2008, Yudkovsky et al., 2000). 
 The transcription factor TFIIS (see section 1.3.2.1.1) has a well-characterised 
role as an elongation factor stimulating transcript cleavage by RNAPII (Fish and Kane, 
2002). However, it can also be found associated with TFIIB, TFIIE and RNAPII, in 
addition to promoter-associated SAGA via its Spt8 subunit, and the Mediator subunit 
Med13 (Pan et al., 1997, Hirst et al., 1999, Wery et al., 2004). This strongly suggests 
that TFIIS has an additional role, in transcription initiation, and supporting evidence 
shows that TFIIS lacking the ability to stimulate transcript cleavage but able to interact 
with RNAPII is able to stimulate PIC formation (Kim et al., 2007). There is, therefore, a 
clear distinction between the elongation and initiation-dependent roles of TFIIS, and 
TFIIS may help promote PIC formation through its affinity for the basal factors and 
RNAPII. Recruitment of TFIIS to the GAL1 promoter is dependent on Mediator and 
SAGA but independent of RNAPII, but TFIIS loss also has an affect on the recruitment 
of TBP and RNAPII to promoters in vivo (Prather et al., 2005). Altogether, this suggests 
that TFIIS plays an important role in PIC recruitment and association during initiation. 
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1.3 Elongation 
 Elongation is a highly regulated process with many auxiliary factors controlling 
and facilitating RNAPII progression across the gene. The process of elongation can 
broadly be divided into two stages: early elongation and processive elongation. 
1.3.1 Early elongation/promoter escape 
 Early elongation is a loosely defined term to describe the phase in which 
promoter escape and formation of the early transcribing complex occurs. Following 
open promoter complex formation, RNAPII begins synthesis of RNA complimentary to 
the DNA template. During this period, the EC is characteristically unstable with a 
tendency to slip backwards on the DNA and release its short nascent transcript, a 
process termed abortive initiation (Pal and Luse, 2002). Footprinting studies of 
prokaryotic RNAP indicate that polymerase is unable to leave the promoter during 
abortive initiation, and that a commitment to stable elongation occurs only after 
production of a 10 nt RNA (Krummel and Chamberlin, 1989, Carpousis and Gralla, 
1985), approximately consistent with the length of the stable DNA-RNA hybrid 
observed in both structural (Gnatt et al., 2001) and biochemical studies (Kireeva et al., 
2000). At a mechanistic level, abortive initiation results from the unproductive release 
of energy stored in a stressed intermediate (Straney and Crothers, 1987). Single-
molecule studies have revealed that RNAP remains stationary at the promoter and pulls 
downstream DNA into itself; an additional turn of DNA unwinding occurs and serves as 
an intermediate to store the energy that facilitates promoter escape (Revyakin et al., 
2006, Kapanidis et al., 2006). Abortive transcription is likely also exacerbated by steric 
collision between RNA and the B-reader loop of TFIIB, which reaches through the 
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RNA exit site towards the active centre of RNAPII. Although this factor stabilises the 
production of short RNAs, it must dissociate to allow the production of longer RNAs. 
This process occurs when the transcript length exceeds 7 nt (Bushnell et al., 2004, 
Kostrewa et al., 2009, Liu et al., 2010). Concomitant with the production of a more 
stable DNA-RNA hybrid, DNA upstream of the bubble collapses, stabilising the EC and 
possibly providing additional energy for promoter escape (Pal et al., 2005). 
 Formation of a 23 nt RNA transcript is associated with increased EC stability 
(Pal and Luse, 2003). Stable ECs have been shown to pause approximately 50 bp 
downstream of the TSS in a process termed promoter-proximal pausing (Marshall and 
Price, 1992, Rahl et al., 2010). The proteins involved in regulating this, and the 
mechanism, are discussed in more detail below. 
1.3.1.1 DSIF, NELF, P-TEFb and promoter-proximal pausing 
 DRB (5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole)-sensitivity-inducing 
factor (DSIF) is an elongation factor initially identified as causing DRB-dependent 
RNAPII pausing in a nuclear-extract-driven transcription system, along with stimulating 
elongation in the absence of DRB (Wada et al., 1998). More recent studies suggest that 
the DRB-dependent transcriptional inhibition actually resulted from contamination of 
the transcription reactions with NELF (discussed in more detail below) (Yamaguchi et 
al., 1999). DSIF is a heterodimeric complex formed of a 160 kDa subunit (p160) and 14 
kDa (p14) subunit, shown to be homologous to yeast Spt5 and Spt4, respectively (Wada 
et al., 1998). Spt4 is a positive elongation factor, with spt4∆ mutants displaying reduced 
mRNA levels, whilst spt4∆ extracts lack processivity when used in in vitro transcription 
assays (Rondon et al., 2003). Spt5 also stimulates elongation, by preventing premature 
termination and pausing during late elongation (Bourgeois et al., 2002). 
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 Negative elongation factor (NELF), another factor involved in promoter-
proximal pausing is a five subunit complex (NELF-A, -B, -C, -D and –E) with no 
known homologue in yeast. NELF induces RNAPII pausing in the presence of DSIF 
through interaction with a DSIF-RNAPII complex (Yamaguchi et al., 1999).  
 NELF and DSIF regulate transcript elongation in concert with a third factor, P-
TEFb (positive transcription elongation factor b), a heterodimeric complex consisting of 
the kinase CDK9 with cyclin T1, T2a, or T2b (Peng et al., 1998a, Peng et al., 1998b). P-
TEFb was identified as a CTD kinase capable of stimulating elongation in vitro 
(Marshall and Price, 1992, Marshall et al., 1996). Later studies in C. elegans provided 
evidence that P-TEFb specifically phosphorylates Ser2 and not Ser5 of the Rpb1 CTD 
(Shim et al., 2002). Yeast does not have a direct homologue of P-TEFb, but the bulk of 
Ser2 phosphorylation is performed by CTDK-I a complex consisting of Ctk1 (a CDK 
homologue), Ctk2 (a cyclin homologue) and Ctk3 (Buratowski, 2009). A recent study 
showed that Ctk1 is homologous to the human cyclin-dependent kinases CDK12 and 
CDK13, which also have CTD-kinase activity (Bartkowiak et al., 2010). Additionally, 
the Bur1/2 kinase (CDK9 in metazoans) is also able to phosphorylate the CTD at Ser2, 
as well as acting upon Spt5 (Qiu et al., 2009, Liu et al., 2009).  
 DSIF/NELF mediates RNAPII arrest during early elongation, with NELF 
competing with the stimulatory factor TFIIF for RNAPII binding (Renner et al., 2001, 
Cheng and Price, 2007). Importantly, promoter-proximal pausing serves as a checkpoint 
for correct pre-mRNA capping, which occurs as a result of the sequential activity of 5’-
triphosphatase, guanylyltransferase and methyltransferase. Capping enzyme is recruited 
and stimulated by the Ser5 phosphorylated Rpb1 CTD (Yue et al., 1997, Ho and 
Shuman, 1999, Moteki and Price, 2002). Additionally, capping enzyme is able to 
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interact directly with both the Spt5 subunit of DSIF and the Rpb1-CTD phosphorylated 
at Ser5 (Wen and Shatkin, 1999, Cho et al., 1997). Early arrest is relieved by P-TEFb-
mediated phosphorylation of both the Rpb1-CTD and the Spt5 subunit of DSIF, which 
causes NELF to dissociate (Yamada et al., 2006, Chen et al., 2009). Capping enzyme 
was also shown to relieve NELF-mediated pausing, possibly providing a feedback 
between correct RNA capping and checkpoint release (Mandal et al., 2004). 
 The loss of NELF from an elongation complex allows movement into the next 
transcription phase, processive elongation. 
1.3.2 Processive elongation 
 It is in this phase of elongation that the bulk of RNA is produced, with RNAPII 
able to synthesise RNA in excess of 2 million nucleotides long without dissociating 
from DNA (Tennyson et al., 1995). Elongation is characterised by high rates of 
transcription, the average reported at between 1.1-1.4 kb per minute (Femino et al., 
1998) and even as high as 50 kb per minute (Maiuri et al., 2011). However, it is 
important to note that these differences in transcription rate are quite distinct from 
RNAPII catalytic rate, which does not change. The source of rate variability is due to 
the fraction of time RNAPII spends in an on-pathway, rather than an off-pathway, state. 
Indeed, in vivo studies have shown several kinetically distinct populations of RNAPII 
interacting with a single specific gene (Darzacq et al., 2007). 
 On-pathway events are those that result in productive catalytic activity, namely 
forward translocation of RNAPII and elongation of the nascent transcript. The 
extraordinary stability of ECs has been mentioned earlier (see section 1.1.1) and in 
agreement with this, single-molecule studies have shown that the EC remains stable 
even when loads of up to 30 pN are applied to it (Dalal et al., 2006, Neuman et al., 2003, 
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Wang et al., 1998). During elongation, RNAPII functions like a Brownian ratchet; there 
is no ATP-dependent ‘power-stroke’ during translocation. RNA polymerases are able to 
move backwards as well as forwards on the DNA template, with forward movement 
favoured through NTP binding and hydrolysis (Kireeva et al., 2000, Bar-Nahum et al., 
2005). 
 Movement of RNAPII into off-pathway states frequently interrupts elongation 
but may be important for regulation and recruitment of appropriate factors such as those 
responsible for mRNA capping, splicing, poly-adenylation and transcription termination 
(de la Mata et al., 2003, Yonaha and Proudfoot, 1999). RNAPII in an off-pathway state 
can be either paused or arrested. Pausing is a transient and common feature during 
elongation, which predominates when forward motion is impeded, for example by DNA 
damage or nucleotide mis-incorporation (Donahue et al., 1994, Jeon and Agarwal, 
1996). The transition of an EC from a paused to an arrested state is a function of the 
dwell time of RNAPII at a pause site (Hawley et al., 1993, Gu and Reines, 1995). 
Arrested ECs are defined as those unable to resume transcription, whilst still being 
catalytically active (Arndt and Chamberlin, 1990, Krummel and Chamberlin, 1992). 
Arrested RNAPII is thus in a backtracked state in which the RNAPII active site is out of 
register with the 3’-OH group of the nascent transcript (Chamberlin, 1992). The 
incorrectly positioned RNA is then extruded and fills the pore of RNAPII, forming 
protein interactions and stabilising the backtracked state (Wang et al., 2009). Factors 
facilitating the re-entry of RNAPII into on-pathway elongation are discussed in the 
following section. 
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1.3.2.1 Factors assisting elongation 
 Factors have evolved to control all aspects of transcript elongation in vivo and 
maintain RNAPII processivity in the presence of blocks to elongation. A selection of 
relevant factors is discussed below. 
1.3.2.1.1 TFIIS 
 A major factor aiding RNAPII in overcoming transcription barriers is TFIIS, a 
protein identified by its ability to stimulate transcript elongation in vitro (Natori et al., 
1973). TFIIS was shown to act after transcription initiation (Sekimizu et al., 1976, 
Reinberg and Roeder, 1987, Sawadogo et al., 1981) by stimulating the extent and 
efficiency of RNA production, but not the rate (Sluder et al., 1989, Reinberg and 
Roeder, 1987, Rappaport et al., 1987, Bengal et al., 1991, Izban and Luse, 1992a). 
TFIIS was also shown to stimulate read-through of A-T-rich DNA sequences, which are 
inhibitory to transcription (Kerppola and Kane, 1990, Hawley et al., 1993) as well as 
stimulate transcription past sequence-specific DNA-binding proteins (Izban and Luse, 
1992a, Reines and Mote, 1993). The mechanism of this was found to result from the 
ability of TFIIS to stimulate transcript cleavage. The transcript cleavage activity is a 
conserved and integral part of RNAP itself, supported by studies showing it to be α-
amanitin-sensitive and independent of accessory factors (Johnson and Chamberlin, 
1994). Intrinsic RNAP-mediated transcript cleavage, however, occurs at a very low rate, 
but is greatly enhanced by accessory factors: the Gre factors in prokaryotes and TFIIS 
in eukaryotes (Orlova et al., 1995, Wang and Hawley, 1993, Rudd et al., 1994). A 
recent study performed in the Svejstrup laboratory isolated a TFIIS mutant able to 
inhibit the intrinsic cleavage activity of RNAPII, which when expressed in vivo resulted 
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in a loss of viability and transcriptional arrest (Sigurdsson et al., 2010). This shows that 
in the absence of functional TFIIS the intrinsic cleavage activity of RNAPII is 
absolutely required, as polymerase arrest must occur frequently in vivo. 
 TFIIS can act on backtracked and arrested ECs, the cleavage activity causing up 
to 17 nt fragments of RNA to be released, whilst realigning the 3’-OH of the RNA in 
the active site to restart transcription (Izban and Luse, 1992b, Izban and Luse, 1993a, 
Izban and Luse, 1993b). Importantly, cleavage factors do not affect the fraction of 
RNAP able to transcribe past an elongation block but instead enable RNAP to have 
multiple attempts at bypass by restarting transcription (Reines, 1992). 
 TFIIS is a single-subunit protein consisting of three domains: I, II and III with a 
19 amino acid linker connecting domains II and III. The N-terminal domain I is a four-
helix bundle dispensable for cleavage activity (Booth et al., 2000), the central domain is 
a three-helix bundle, which forms an additional three helices upon RNAPII interaction 
(Morin et al., 1996, Olmsted et al., 1998, Kettenberger et al., 2003), and the C-terminal 
domain III is a zinc-ribbon fold with a β-hairpin, containing the activating acidic loop 
(Olmsted et al., 1998, Qian et al., 1993). The linker residues between domains II and III 
are necessary for TFIIS activity and have been shown to confer species-specificity 
(Shimasaki and Kane, 2000, Awrey et al., 1998).  
 Structural studies have helped elucidate the mechanism of TFIIS activity 
(Kettenberger et al., 2003, Kettenberger et al., 2004). Domains II, III and the linker are 
required for RNAPII binding by TFIIS. Domain II docks to the Rpb1 jaw domain, the 
linker passing through and opening a crevice on RNAPII causing structural 
rearrangements, and domain III inserts into the RNAPII pore entering the active site 
(Kettenberger et al., 2003). The β-hairpin of domain III becomes highly ordered through 
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extensive contacts with RNAPII, including interactions with the trigger loop and bridge 
helix, and causes a 4 Å shift in the position of the RNA (Kettenberger et al., 2004). Two 
highly conserved acidic residues in the β-hairpin are required for TFIIS activity (Jeon et 
al., 1994), which occurs through the co-ordination of two catalytic metal ions by the 
acidic residues, in a manner similar to DNA cleavage by the Klenow DNA polymerase 
(Beese and Steitz, 1991, Joyce and Steitz, 1994, Kettenberger et al., 2004). TFIIS 
aspartate 290 in the acidic residue patch directly contacts and activates a nucleophilic 
water molecule for an SN2 attack on the RNA phosphodiester bond (Kettenberger et al., 
2004, Wang et al., 2009). This model is in agreement with a requirement for divalent 
metal ions for RNA cleavage by RNAPII-TFIIS (Izban and Luse, 1992b, Reines, 1992, 
Wang and Hawley, 1993, Weilbaecher et al., 2003). 
 Control of TFIIS can be achieved through phosphorylation of serine and 
threonine residues in domain I (Sekimizu et al., 1981) resulting in the inability of TFIIS 
to stimulate elongation in a reconstituted system. However, phosphorylated TFIIS is 
still active when added to purified RNAPII (Hirai et al., 1988).  
1.3.2.1.2 TFIIF 
 Yeast TFIIF is a complex consisting of three proteins, Tfg1, Tfg2 and Tfg3, the 
first two being homologous to human RAP74 and RAP30, but the latter having no 
known mammalian counterpart. TFIIF has roles in both initiation and elongation, where 
it has been shown to stabilise TFIIB in the PIC (Cabart et al., 2011), suppress abortive 
initiation and stimulate promoter escape, whilst functioning in tandem with TFIIH to 
prevent arrest of early elongation intermediates (Yan et al., 1999). Although a recent 
genome-wide study showed that TFIIF is most commonly localised to promoter regions 
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(Mayer et al., 2010), it has also been found at the 3’ ends of human genes (Cojocaru et 
al., 2008). During elongation, TFIIF stimulates elongation by re-associating with stalled 
ECs to convert them into an elongation-competent form (Zawel et al., 1995) and co-
operates with TFIIS to regulate RNAPII processivity (Zhang et al., 2003). 
1.3.2.1.3 Elongins 
 The Elongin complex (SIII) is a three-subunit complex consisting of Elongin A, 
the active subunit and regulatory subunits Elongins B and C (Bradsher et al., 1993a, 
Aso et al., 1995, Aso et al., 1996, Garrett et al., 1995, Takagi et al., 1996). Studies have 
shown that like TFIIF, the Elongin complex has a positive role in transcript elongation, 
achieved through suppression of transient EC pausing, but unlike TFIIF is not required 
for PIC formation and has no other roles during initiation (Bradsher et al., 1993b). Data 
suggests that the effect of Elongin and TFIIF on ECs are mutually exclusive, as TFIIF 
must be lost in order to confer Elongin-sensitivity (Moreland et al., 1998). Very little is 
known about the precise molecular mechanism of Elongin action but it has been 
suggested that it is able to realign the 3’-OH end of the nascent transcript in the RNAPII 
active site (Takagi et al., 1995). Other Elongin A-related proteins have been discovered 
(Elongins A2 and A3), which are able to stimulate elongation but are not regulated by 
Elongin B or Elongin C.   
 In yeast, the proteins Elc1 and Ela1 are homologues of Elongins C and A, 
however, no Elongin B homologue has been identified (Aso and Conrad, 1997). Unlike 
the mammalian proteins, Ela1 and Elc1 are unable to stimulate transcript elongation 
(Koth et al., 2000), but have been shown to have a role in RNAPII poly-ubiquitylation 
and degradation (Ribar et al., 2006, Ribar et al., 2007, Harreman et al., 2009)
Chapter 1 Introduction 
 37 
will be discussed in more detail later. Not surprisingly, mammalian Elongins also have 
a role in ubiquitylation. Elongins B and C form a stable complex with the von Hippel-
Lindau tumour suppressor protein (pVHL), Cul2 and Rbx1. This complex is remarkably 
similar to the yeast complex of Ela1, Elc1, Cul3 and Roc1 and in support of them 
having a similar role, mammalian Elongin C is homologous to yeast Skp1, a subunit of 
the SCF complex, which targets proteins for poly-ubiquitylation and degradation (Ribar 
et al., 2007, Harreman et al., 2009, Ivan and Kaelin, 2001). Furthermore, the 
ElonginBC-pVHL complex has been shown to target hypoxia-inducible factor (HIF) for 
proteasome-mediated degradation; however, further studies are necessary to fully 
elucidate the role of the Elongins and their various complexes in transcript elongation 
(Ivan and Kaelin, 2001, Conaway and Conaway, 2002). 
1.3.2.1.4 ELL family proteins 
 ELL is a product of the eleven-nineteen lysine-rich leukaemia gene and was 
found to be functionally analogous to TFIIF and Elongin, with the ability to aid RNAPII 
processivity by suppressing transcriptional pausing, thus limiting the amount of time 
spent by RNAPII in an off-pathway state (Shilatifard et al., 1996). There are three ELLs 
in humans designated ELL1, ELL2 and the testis-specific ELL3, all of which have 
stimulatory roles during elongation (Shilatifard et al., 1997, Miller et al., 2000).  
 Drosophila has a single homologue of ELL (dELL) which co-localises with 
RNAPII on polytene chromosomes and is essential for normal development, suggesting 
that it plays a non-redundant role in elongation, distinct from that of Elongin and TFIIF 
(Gerber et al., 2001, Eissenberg et al., 2002). Additionally, mutations in the gene 
encoding dELL result in transcription defects, the effect of which is mainly confined to 
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longer genes (Eissenberg et al., 2002, Shilatifard, 2004). This is consistent with ELL 
having an important role in transcript elongation. 
 In addition to interacting with RNAPII, ELL proteins have been shown to exist 
in other complexes. The first complex is with ELL-associated proteins EAP20, EAP30 
and EAP45, which has positive elongation activity and lacks the uncharacterised 
negative activity that ELL alone can have on elongation in vitro (Shilatifard, 1998). 
ELL has also been shown to be part of the super elongation complex (SEC) a multi-
protein complex with several different sub-forms, consisting of: P-TEFb, AFF1, AFF4 
(the main scaffold protein), ELL1, ELL2, ENL and AF9 (Sobhian et al., 2010, He et al., 
2010, Lin et al., 2010, Yokoyama et al., 2010, Mueller et al., 2009). The SEC is able to 
interact with the PAF complex (a multi-functional complex which has a role in 
elongation, co-transcriptional histone modification and mRNA biogenesis (Zhou et al., 
2012)) and is required for efficient induction of some rapidly-induced genes in response 
to differentiation signals in metazoans (Sobhian et al., 2010, Lin et al., 2011). These 
data are consistent with those obtained in Drosophila and implicate ELL in 
development and differentiation.  
1.3.3 Blocks to transcription 
1.3.3.1 Chromatin  
 All DNA metabolic events occur in the context of chromatin, the basic unit of 
which is the nucleosome, an octameric protein complex consisting of two of each of the 
core histones H2A, H2B, H3 and H4 (Kornberg and Lorch, 1999). Histones H2A and 
H2B interact to form a dimer as do histones H3 and H4. Nucleosomes are encircled by 
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approximately 147 bp of DNA and have the ability to regulate protein-DNA interactions, 
such as those between GTFs and promoter DNA (Luger et al., 1997, Luger, 2006).   
 The structure of chromatin is important for DNA metabolism, alteration of its 
state either allows or inhibits the occurrence of such processes. The presence of 
chromatin has an impact on the efficiency of transcription. Indeed, linear poly-
nucleosomal arrays inhibit RNAPII elongation in vitro, but RNAPII is able to transcribe 
past single nucleosomes (Lorch et al., 1987, Izban and Luse, 1991, Orphanides et al., 
1998). Biochemical studies performed by the Kashlev laboratory have shown that 
RNAPII has the ability to cause dissociation of the H2A/H2B dimer from a nucleosome 
when transcribing through it (Kireeva et al., 2002). Further work has shown that a 
proportion of RNAPII backtracks following pausing at a nucleosome and that TFIIS, or 
the presence of a trailing RNAPII molecule, helps reduce backtracking of the leading 
polymerase, aiding nucleosome bypass (Kireeva et al., 2005, Jin et al., 2010). Such 
bypass is likely to be the result of elongating RNAPII stripping DNA off the surface of 
the nucleosome, and this is supported by the finding that RNAPII does not change the 
position of the nucleosome on DNA whilst transcribing past it (Kireeva et al., 2005, 
Kireeva et al., 2002). 
 In addition to the intrinsic, albeit inefficient, ability of RNAPII to transcribe 
through nucleosomes, factors have evolved to change the state of chromatin, facilitating 
the progression of RNAPII and alleviating the role of chromatin as a transcriptional 
block. These factors fall into three broad groups and some key examples of each are 
discussed below.  
 The first group are ATP-dependent chromatin remodellers, in which four 
families have been identified: SWI-SNF, ISWI, CHD and INO80/SR. This group of 
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remodellers is able to use the energy stored in ATP to alter the position of nucleosomes 
on DNA, as well as destabilise or eject them; activities essential for correct promoter 
function and allowing PIC proteins access to their respective binding sequences 
(Clapier and Cairns, 2009, Schnitzler, 2008). In addition to promoter-based remodelling, 
this group of factors has been shown to influence chromatin on coding regions. For 
example, RSC was shown to increase mono-nucleosome bypass efficiency in vitro 
through its SWI-SNF remodelling activity (Carey et al., 2006). 
 The second group are histone chaperones, proteins involved in the dynamic 
assembly and disassembly cycle of nucleosomes. FACT (facilitates chromatin 
transcription) was the first chaperone found to have a role in transcript elongation and 
does so by destabilising the nucleosome and aiding in the removal of an H2A/H2B 
dimer upon RNAPII passage, probably aiding stripping of DNA off the surface of the 
nucleosome by the transcribing polymerase (Belotserkovskaya et al., 2003). The NAP-
like family of histone chaperones also have transcription-associated roles: Vps75 binds 
histones and has been implicated in RNAPII progression during transcription (Selth and 
Svejstrup, 2007, Selth et al., 2009). Another key example of a histone chaperone is Spt6, 
an H3/H4 binding protein, which has a role in the maintenance of chromatin structure in 
yeast and specifically the restoration of chromatin structure following RNAPII 
progression across a gene (Bortvin and Winston, 1996). In support of this, studies have 
shown that Spt6 is required to prevent cryptic transcription occurring at the 3’ end of 
genes (Kaplan et al., 2003). Therefore, this group of proteins can be thought of as 
nucleosome ‘recyclers’.  
 The final group are covalent histone modifying proteins, enzymes with the 
ability to transfer a chemical moiety or protein (e.g. ubiquitin) to histones. The 
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protruding, unstructured amino-terminal ‘tails’ of histones are the targets for a diverse 
array of post-translational modifications, which serve to alter the packaging and 
structure of chromatin, as well as provide a binding surface for histone-associated 
proteins (Luger et al., 1997). The three modifications that will be discussed are: 
acetylation, methylation and ubiquitylation. 
 
1.3.3.1.1 Acetylation of histones  
 Histone acetylation occurs through the activity of histone acetyltransferases 
(HATs), which use acetyl-CoA as a substrate for the reaction. This activity is 
antagonised by histone deacetylases (HDACs), which remove the modification. Both 
HATs and HDACs are found in the coding region of genes, suggesting substantial 
cycling of acetylation on active genes (Carrozza et al., 2005, Wang et al., 2002, Gilbert 
et al., 2004, Close et al., 2006, Keogh et al., 2005, Govind et al., 2007).  
 In support of a role for acetylation in elongation, mutants of the Elongator HAT 
complex, a complex isolated through its interaction with elongating RNAPII (Otero et 
al., 1999), display hypoacetylation of histones on the coding region of genes and 
transcriptional impairment (Kristjuhan et al., 2002). Additionally, Elongator is able to 
stimulate transcription on a chromatin template in vitro, suggesting that acetylation 
occurs co-transcriptionally (Otero et al., 1999, Wittschieben et al., 1999, Svejstrup, 
2007b, Kim et al., 2002). It seems that this is not a feature unique to Elongator, as the 
p300/CBP-associated factor (PCAF) also binds hyper-phosphorylated RNAPII and is 
required for efficient elongation on a chromatin template in vitro (Cho et al., 1998, 
Obrdlik et al., 2008, Guermah et al., 2006). The SAGA subunit Gcn5 has also been 
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implicated in co-transcriptional acetylation, as H3 acetylation levels are reduced in the 
coding regions of gcn5∆ mutants, which show elongation and nucleosome eviction 
defects (Kristjuhan and Svejstrup, 2004, Govind et al., 2007, Kristjuhan et al., 2002, 
Govind et al., 2005). This highlights the importance of this co-transcriptional event in 
allowing processive elongation to occur. 
 In addition to the role of acetylation in elongation, hyperacetylation is a 
hallmark of active promoters and probably serves to relax chromatin structure in 
addition to recruiting ATP-dependent remodellers such as SWI-SNF (Workman and 
Kingston, 1998, Pokholok et al., 2005, Hassan et al., 2001). Therefore, this chromatin 
modification is necessary for the correct function of transcription at multiple different 
stages. 
 
1.3.3.1.2 Histone methylation and ubiquitylation 
 The role of histone methylation is less defined than that of acetylation, as the 
addition of this small chemical group is unlikely to cause significant structural changes 
in chromatin. It is much more likely that this modification acts as a platform for 
recruitment of effector proteins containing chromodomains, PHD and tudor domains 
(Daniel et al., 2005). The addition of methyl groups to histones occurs via the action of 
histone methyltransferases (HMTs), which are able to mono-, di-, or tri-methylate 
histone H3, whilst demethylases serve to remove this modification. 
 There are several methylation marks associated with transcription, of which a 
few shall be discussed in further detail in this section. Co-transcriptional methylation 
occurs at H3K36 in coding regions as a result of the association between the HMT Set2 
Chapter 1 Introduction 
 43 
and RNAPII, via the Ser2 phosphorylated form of the CTD (Krogan et al., 2003, Li et 
al., 2003, Schaft et al., 2003, Xiao et al., 2003). The accumulation of di- and tri-
methylated H3K36 in coding regions is, in turn, responsible for recruitment of the 
Rpd3S HDAC complex (Li et al., 2009). The methyl mark serves as a platform for 
binding of the Eaf3 and Rco1 subunits of the HDAC, via their respective 
chromodomain and PHD domain, ultimately leading to co-transcriptional histone de-
acetylation (Carrozza et al., 2005, Keogh et al., 2005, Joshi and Struhl, 2005, Li et al., 
2009, Li et al., 2007). These findings suggest that H3K36 methylation has a regulatory 
role in the transcription-associated acetylation-deacetylation cycle. 
 A further modification is histone ubiquitylation. In addition to its role in 
targeting proteins for degradation, generally associated with the addition of ubiquitin 
chains (poly-ubiquitylation), addition of one ubiquitin moiety (mono-ubiquitylation) 
serves as a signalling mark, resulting in a variety of downstream effects (Pickart, 2001). 
Mono-ubiquitylation of histone H2B, which occurs at K123 (K120 in mammals) is no 
exception. This histone mark occurs as a consequence of transcriptional activation and 
is found at promoters and coding regions (Henry et al., 2003, Kao et al., 2004, Xiao et 
al., 2005). H2B mono-ubiquitylation requires active transcription and is dependent on 
the TFIIH kinase, which phosphorylates Ser5 of the Rpb1-CTD, marking the transition 
from initiation to elongation (Xiao et al., 2005). The mechanism of H2B ubiquitylation 
is a complex one, requiring multiple factors. Transcribing RNAPII associates with the 
elongation factor Spt5, which can be phosphorylated by the Bur1/2 kinase. Spt5 
phosphorylation leads to the recruitment of the Paf complex (Liu et al., 2009, Zhou et 
al., 2009), which associates with the Rad6/Bre1/Lge1 complex and mono-ubiquitylates 
histone H2B (Weake and Workman, 2008). 
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 Histone H2B mono-ubiquitylation is important for RNAPII movement through 
the coding region of genes and is associated with histone H3 methylation. Methylation 
of H3K4 (performed by Set1 in yeast and MLL in humans, part of the COMPASS 
complex) and H3K79 (performed by Dot1) are linked to H2B ubiquitylation (Gerber 
and Shilatifard, 2003). H3K4 mono-methylation is able to occur in the absence of 
ubiquitylated H2B, but the Cps35 subunit of COMPASS, required for the subsequent 
di- and tri-methylation is absent (Lee et al., 2007). Furthermore, the requirement of 
ubiquitylated H2B in H3K79 methylation is likely mediated by Cps35, which is able to 
interact with Dot1 and is required for efficient H3K79 methylation (Selth et al., 2010). 
Although the exact mechanism of this is unclear, it highlights the interplay between 
different histone modifications and their ultimate effect on transcript elongation. 
 In addition to the indirect effects of histone H2B ubiquitylation on transcript 
elongation, there are also more direct effects. This histone mark has been shown to 
enhance RNAPII transcription on nucleosomal templates in vitro, probably as a result of 
FACT-dependent histone H2A/H2B dissociation and has been shown to stimulate 
FACT activity (Pavri et al., 2006, Fleming et al., 2008). Furthermore, ubiquitylated 
H2B is involved in nucleosome reassembly in the wake of RNAPII transcription. 
Mutant H2B that could not be ubiquitylated showed a reduction in re-assembly of 
nucleosomes at highly expressed genes (Batta et al., 2011), a phenomenon dependent on 
the Chd1 chromatin remodeller (Lee et al., 2012). 
 In conclusion, chromatin forms a barrier to transcription at various stages of the 
transcription cycle. The presence of chromatin prevents cryptic initiation events, as well 
as unscheduled initiation, adding another level of control to gene expression. The 
Chapter 1 Introduction 
 45 
presence of accessory factors allows control of transcription at the level of elongation 
and can facilitate the passage of RNAPII through this strong transcription inhibitor.  
1.3.3.2  DNA damage and RNAPII ubiquitylation 
 DNA lesions arising from endogenous and exogenous damaging agents form a 
block to elongation and thus interrupt gene traffic. RNAPII can transcribe past helix-
distorting lesions such as cyclobutane pyrimidine dimers (CPDs) in vitro, but bypass is 
extremely slow and inefficient (Brueckner et al., 2007, Walmacq et al., 2012), and may 
not occur often in vivo. Other forms of DNA damage are also a problem: O6-
Methylguanine lesions impair elongation, but to a much lesser extent than the bulky 
lesions (Dimitri et al., 2008), whilst transcription factors have been shown to aid in the 
bypass of non-bulky thymine glycol (TFIIF, Elongin, CSB) and 8-oxoguanine lesions 
(Elongin, CSB, TFIIS), presumably by suppressing RNAPII pausing and arrest 
(Charlet-Berguerand et al., 2006). Upon encountering a damage site, especially one 
containing a bulky lesion, RNAPII pauses and eventually arrests. This has two results: 
blockage of the gene preventing further transcription, and initiation of transcription-
coupled nucleotide excision repair (TC-NER) (Saeki and Svejstrup, 2009, Donahue et 
al., 1994, Svejstrup, 2007a, Svejstrup, 2003). Arrested RNAPII is also inhibitory to 
other metabolic events occurring on DNA; therefore, it can be necessary to remove 
immobile RNAPII from the gene.  
 Removal of arrested RNAPII from a gene occurs via ubiquitylation and 
degradation of the Rpb1 subunit. This represents a last resort pathway, occurring as a 
result of irreversibly arrested RNAPII, rather than as a DNA damage response per se 
(Woudstra et al., 2002, Anindya et al., 2007, Somesh et al., 2005, Sigurdsson et al., 
2010). Clearance of RNAPII from a coding region results in the continuation of 
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transcription by trailing polymerases, or, if damage is still present (if TC-NER did not 
occur), access of proteins responsible for its repair (general genome nucleotide excision 
repair, GG-NER).  
 Ubiquitylation of yeast RNAPII occurs at two key lysine residues of Rpb1: 
K330 and K695 (Somesh et al., 2007). As in all ubiquitylation pathways, a triple-
enzyme cascade is responsible for Rpb1 ubiquitylation, consisting of an: E1 (activating 
enzyme), E2 (conjugating enzyme) and E3 (ligating enzyme). Both in vitro and in vivo 
studies have shown Rsp5 to be the E3 involved in Rpb1 ubiquitylation post-DNA 
damage, where it associates with the Rpb1-CTD (Somesh et al., 2005, Harreman et al., 
2009, Beaudenon et al., 1999). Furthermore, this reaction can be reconstituted in vitro 
using the highly purified factors: Uba1, Ubc5 and Rsp5 (as the E1, E2 and E3, 
respectively) (Harreman et al., 2009, Somesh et al., 2005). Surprisingly, utilising Rsp5 
in vitro results in the formation of lysine-63-linked (K63) poly-ubiquitin chains, which 
are not detected on RNAPII in vivo. However, the Rsp5-associated de-ubiquitylation 
enzyme (DUB) Ubp2 has been shown to recognise K63-linked chains and trim them 
back to a single mono-ubiquitin moiety on Rpb1, probably antagonising the formation 
of unphysiological ubiquitin chains in vivo (Kee et al., 2005). Importantly, these data 
suggested that additional factors are necessary for productive poly-ubiquitylation. 
 Subsequent studies discovered a role for the Elongin-Cullin complex (Elc1, Ela1, 
Cul3 and Roc1 (Rbx1)) in Rpb1 ubiquitylation and degradation in vivo, suggesting it 
could be the main E3 ubiquitin ligase (Ribar et al., 2006, Ribar et al., 2007). 
Purification of the Elongin-Cullin complex and its use in biochemical assays has 
revealed that it is the second E3 ubiquitin ligase, acting in a two-step mechanism with 
Rsp5 (Harreman et al., 2009). A more complete model has now been elucidated in 
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which Rsp5 ubiquitylates Rpb1 following irreversible arrest, whilst Ubp2 trims back 
any K63-linked poly-ubiquitin chains to a single mono-ubiquitin moiety on Rpb1 
(Figure 1.3, steps 1 and 2). The mono-ubiquitylated intermediate is then recognised by 
the second E3 ubiquitin ligase, the Elongin-Cullin complex, which mediates K48-linked 
poly-ubiquitylation, resulting in proteasome-mediated Rpb1 degradation (Figure 1.3, 
steps 3 and 4) (Harreman et al., 2009). This multi-step process likely helps ensure that 
RNAPII is only degraded as a last resort when transcription problems are encountered. 
 Another factor, Def1 (RNAPII degradation factor 1), is also essential for 
RNAPII poly-ubiquitylation, and like cells lacking subunits of the Elongin-Cullin E3 
ligase, def1∆ mutants still contain mono-ubiquitylated Rpb1, showing they are not 
required for this Rsp5-mediated initial step (Woudstra et al., 2002, Somesh et al., 2005). 
The precise mechanism of Def1 function is currently unknown. However, it associates 
with RNAPII after DNA damage and can accelerate Rpb1 ubiquitylation in vitro 
(Somesh et al., 2005, Reid and Svejstrup, 2004).  
 Initiation of the ubiquitylation pathway does not necessarily result in 
degradation of RNAPII and there is in fact a proofreading element allowing reversal of 
poly-ubiquitylation. Another DUB, Ubp3, is capable of removing K48-linked chains 
and can even hydrolyse the bond between K330/K695 and the mono-ubiquitin moiety 
(Kvint et al., 2008). Therefore, Ubp3 can be thought of as a ubiquitylation proofreading 
protein and represents a checkpoint for ubiquitylation and degradation, allowing its 
reversal.  
 To summarise, bypass of DNA damage is inefficient and effectively requires the 
repair of the damaged DNA to allow the resumption of transcription. However, cells  
 




Figure 1.3 Ubiquitylation and degradation of Rpb1 
RNAPII stalled at a damage lesion on DNA (yellow star) (Step 1) is mono-ubiquitylated by 
Rsp5, which is associated with Ubp2, a DUB able to trim back any K63-linked poly-ubiquitin 
chains (Step 2). This is followed by poly-ubiquitylation by the Elongin-Cullin complex, 
facilitated in an unknown manner by Def1 (Step 3). The K48-linked poly-ubiquitin chains 
target the Rbp1 subunit of RNAPII for proteasome-mediated degradation (Step 4). 
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have evolved a pathway to deal with arrested RNAPII, allowing it to be removed to 
allow more time for access of the repair machinery to the lesion.  
1.4 Termination 
 Termination is the final stage of the transcription cycle and is essential for 
successful gene expression. It is in this stage that the nascent RNA is released and the 
ternary complex disrupted, allowing RNAPII to be recycled back to the promoter (of the 
same or other genes) for further rounds of transcription. Termination can be broadly 
divided into two sections, termination of poly(A) mRNA and termination of non 
poly(A) transcripts. 
1.4.1 Termination of protein-coding genes 
 At the 3’ end of a gene, RNAPII encounters regulatory elements required for 
processing of the nascent transcript and the subsequent events associated with 
termination. One such well-characterised sequence element is the poly(A) signal (PAS), 
which is degenerate in yeast but has the consensus sequence AAUAAA in humans 
(Proudfoot, 2011). The PAS has a major role in termination, as it is responsible for the 
initiation of 3’ nascent mRNA processing. Upon transcribing this element the transcript 
is processed by endonucleolytic cleavage and stabilised via the addition of a poly(A) 
tail (of 70 nt in yeast and 200 nt in humans)  (Bienroth et al., 1993). It is essential that 
during 3’ processing, RNA cleavage and the subsequent polyadenylation occur at the 
correct positions in the nascent transcript. This is reliant upon other less conserved 
sequence recognition elements present at the PAS. At most genes they consist of three 
elements: an adenine-rich efficiency element with the consensus sequence TAYRTA, a 
pyrimidine-rich positioning element with the consensus AAWAAA (located 
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approximately 30 nt upstream of the cleavage site) and a uridine-rich element, which 
spans the cleavage position and the poly(A) addition site (Guo and Sherman, 1995, 
Bardwell et al., 1991, Dichtl and Keller, 2001, Valentini et al., 1999). 
 Two multimeric protein complexes are responsible for catalysing the cleavage 
and poly-adenylation of pre-mRNA and have subunits that interact with the PAS and its 
associated elements. These complexes, CPF (cleavage and polyadenylation factor) and 
CF (cleavage factor I A and B), are transferred from the Rpb1-CTD onto their substrate, 
the nascent mRNA, where cleavage of the RNA is catalysed by the Ysh1 subunit and 
the subsequent poly-adenylation catalysed by the poly(A) polymerase Pap1, which 
interacts with CPF (Keller and Minvielle-Sebastia, 1997, Ryan et al., 2004, Mandel et 
al., 2006, Zhelkovsky et al., 2006, Bienroth et al., 1993, Wahle, 1991, Kuhn et al., 2009, 
Ezeokonkwo et al., 2012). The association of these complexes with RNAPII is 
dependent on the Pcf11 subunit of CFI and its binding is highly co-ordinated. 
Interestingly, recent work has shed light on this regulation, showing that Pcf11 binds 
Ser2 phosphorylated Rpb1-CTD, but only in the absence of Tyr1 and Ser5 
phosphorylation (Mayer et al., 2012).  The presence of Tyr1 phosphorylation across the 
vast majority of the gene may therefore act as a safeguard to ensure against premature 
termination should RNAPII transcribe a sequence resembling the PAS. 
 Upon completion of 3’ processing events, the pre-mRNA is converted into 
mature mRNA ready for export and translation. However, RNAPII is still associated 
with the DNA template and, surprisingly, actually continues producing transcript a long 
way past the PAS. Regulation and transcription of downstream genes can be affected by 
continued transcription of RNAPII into downstream promoters, so it must be removed 
from the DNA (Greger et al., 2000).  Removal of RNAPII from the gene after transcript 
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cleavage is poorly understood, but must occur via EC destabilisation, with two main 
models having been proposed for how this could occur: the allosteric model and the 
torpedo model. 
 The allosteric model suggests that upon transcription of the PAS there is a 
change in the factors associated with RNAPII, specifically the loss of factors promoting 
processive elongation and binding of negative elongation factors (Logan et al., 1987). 
This model has been supported by studies in mammalian cells, which indicate that 
termination can be separated into two distinct stages: EC pausing and RNAPII 
dissociation (Park et al., 2004). 
 The torpedo model suggests that following cleavage of pre-mRNA and its poly-
adenylation, a new 5’ end is generated on the RNA still connected to the RNAPII active 
site (Connelly and Manley, 1988). As this transcript is un-capped, it could act as an 
entry point for either a 5’-3’ exonuclease or helicase activity, which could move along 
the nascent RNA, catch up with the polymerase, and cause EC destabilisation. In 
support of this model, a 5’-3’ exonuclease, Rat1, was found to promote termination in 
yeast by degrading the nascent transcript downstream of the PAS (Kim et al., 2004). 
Furthermore, inactivation of both Rat1 and its human homologue Xrn2 show 
termination defects, resulting in read-through of normal termination sites (Kim et al., 
2004, West et al., 2004). For the dissociation factor to remove polymerase it is 
presumably necessary for the exonuclease/helicase to catch-up with it, which could be 
made possible by RNAPII pausing downstream from the transcript cleavage site. Thus, 
it seems likely that the actual mechanism of termination utilises a mixture of the 
allosteric and torpedo models. RNAPII likely pauses at and after the PAS, the transcript 
is cleaved and poly-adenylated, prior to Rat1 being loaded onto the nascent transcript, 
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which it degrades. Upon contact with RNAPII, Rat1 could cause the release of the 
remaining transcript, subsequently leading to EC destabilisation, in a manner similar to 
that of bacterial Rho factor (Epshtein et al., 2010). Alternatively, and arguably more 
closely related to the bacterial mechanism, the Sen1 RNA helicase, which has a role in 
non-coding RNA termination (at snoRNA genes), could also act as the EC 
destabilisation factor (Kawauchi et al., 2008, Rondon et al., 2009, Steinmetz et al., 
2001). Further studies are necessary to fully comprehend this mechanism, but given the 
lack of dramatic termination phenotypes associated with mutation of any individual 
gene encoding a ‘torpedo’- or EC-destabilising factor, it is probable that the interplay 
between multiple factors is required for efficient termination. 
1.4.2 Termination of non-coding RNAs 
 RNAPII not only transcribes all protein-coding genes, but is also responsible for 
the expression of some stable non-coding RNAs. Processing of the latter transcripts 
differs from that of mRNA. Non-coding RNAs generally lack poly(A) tails and are 
subject to a different form of termination. Termination of small nucleolar RNAs 
(snoRNAs) is by far the most extensively characterised of the non-coding RNA 
termination processes.  
 SnoRNA termination occurs through the action of the trimeric NRD complex 
consisting of: Nrd1, Nab3 and Sen1 (Rasmussen and Culbertson, 1998, Steinmetz et al., 
2001). Both Nrd1 and Nab3 have a role in RNA binding and contain RNA recognition 
motifs (RRMs) (Steinmetz and Brow, 1996, Hobor et al., 2011). Additionally, Nrd1 is 
responsible for the association of the NRD complex with RNAPII, via its CTD-
interacting domain (CID), which can associate with the Rpb1-CTD (Vasiljeva et al., 
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2008). The third subunit, Sen1, is an RNA helicase, as mentioned previously (see 
section 1.4.1). 
 Sites of snoRNA termination are defined by arrays of two motifs: the first, 
UCUU, forms a binding site for Nab3, whilst the second, GUA(A/G), binds Nrd1 
(Carroll et al., 2004). Following interaction of the NRD complex with the nascent RNA, 
it has been suggested that the RNA is processed by the NRD-associated exosome 
complex (Carroll et al., 2007, Carroll et al., 2004, Vasiljeva and Buratowski, 2006). 
Finally, in a similar manner to that proposed for the torpedo model, Sen1 acts as a Rho-
like factor and is able to disrupt the EC, leading to RNAPII dissociation (Chinchilla et 
al., 2012). 
 Although the proteins involved in ncRNA termination are different from those 
involved in termination of poly-adenylated transcripts, they most certainly share a 
common theme. It is also very likely that there is redundancy between the two pathways, 
probably providing a failsafe mechanism for termination (Kawauchi et al., 2008, 
Rondon et al., 2009).  
 
1.5 The transcriptional landscape 
 The transcriptome is made up of two main classes of RNA: mRNA, which forms 
the template for protein synthesis, and non-coding RNA (ncRNA), a large 
heterogeneous group of RNA, much of which has no known function. This section will 
focus on the organisation of the genome into distinct gene units, before discussing 
pervasive transcription, and the manner in which the two classes of transcripts and the 
RNAPII molecules producing them may interact. 
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1.5.1 Orientation of protein-coding genes 
 Gene units arranged on DNA can be divided into pairs and the arrangement 
classified by the spatial orientation of the genes within the pair. Gene pairs can be 
arranged tandemly, divergently, or convergently (Figure 1.4). Tandem pairs are 
arranged in a head-to-tail configuration, with the terminator of one gene being spatially 
close to the promoter of the next (Figure 1.4A). In this configuration the transcribed 
(sense) strands of the two genes are the same. Divergent pairs are arranged head-to-head 
so that the promoters are spatially close, each being transcribed away from the other on 
the opposite DNA strand (Figure 1.4B). Finally, convergent genes are arranged in a tail-
to-tail configuration, with RNAPII molecules from each gene transcribing towards the 
other, on opposite strands of DNA (Figure 1.4C).  
 The orientation of genes has implications for their transcription and regulation. 
For example, many expression profile studies have shown that neighbouring genes are 
co-regulated. Divergent and tandem gene pairs show strong positive expression 
correlation (i.e. the pair are transcribed simultaneously) (Kraakman et al., 1989, Nakao 
et al., 1986, Osley et al., 1986, West et al., 1984, Cohen et al., 2000), whilst convergent 
pairs often negatively affect each other’s expression (Xu et al., 2011, Hongay et al., 
2006). Furthermore, as a result of the compact nature of the yeast genome, many of the 
genes that are arranged convergently overlap at their 3’ ends. Presumably, simultaneous 
expression of genes would result in RNAPII interaction and possibly collision, likely 
affecting the transcripts produced. A final gene class, observed mainly in higher 
eukaryotes, is nested genes (genes-within-genes), which are embedded in the body of 
another gene in either a sense or antisense orientation (Figure 1.4D, an antisense 
embedded gene). An example of an antisense nested gene is F8A (Factor VIII- 







Figure 1.4 Orientation of gene pairs. 
A. Schematic showing GENE A (grey) and GENE B (white) arranged as a tandem gene pair. 
Arrow indicates promoter position and direction of transcription. B. GENE A and GENE B 
arranged divergently. C. GENE A and GENE B arranged convergently. D. A nested gene pair, 
showing GENE B within GENE A, in a convergent orientation.  
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associated gene A), which encodes HAP40, a huntingtin-associated protein. F8A is 
found in intron 22 of the Factor VIII gene, and transcribed convergently to it (Levinson 
et al., 1990, Peters and Ross, 2001). 
1.5.2 Non-coding RNA production 
 The second class of transcripts is the ncRNAs. These include RNAPI and 
RNAPIII-synthesised transcripts, such as ribosomal RNAs and tRNAs, but the focus 
here will be on RNAPII-synthesised ncRNAs, which includes snoRNAs, but also 
multiple other transcripts, often of unknown function. With the advent of micro-array 
analysis and subsequently next-generation sequencing, came the discovery of a large 
number of un-annotated transcripts, which had previously been disregarded as artefacts. 
Indeed, the genomes of diverse organisms, such as yeast (David et al., 2006, Dutrow et 
al., 2008, Nagalakshmi et al., 2008, Wilhelm et al., 2008), plants (Li et al., 2006), 
Drosophila (Stolc et al., 2004) and mammals (Bertone et al., 2004, Carninci et al., 2005, 
He et al., 2008) show extensive transcription, not resulting in the production of a stable 
transcript. This transcription is disproportionate to the number of protein-coding genes 
present, in S. cerevisiae which contains 5,654 open reading frames (ORFs), up to 85% 
of the entire genome is transcribed (David et al., 2006). These additional transcripts 
were found to arise from transcription of intergenic regions, as well as from overlapping 
transcription within genes (David et al., 2006, Xu et al., 2009). ncRNAs can overlap 
extensively with protein-coding genes and these can be transcribed in a sense (tandem) 
or antisense (convergent) orientation in relation to the gene. Genome-wide studies have 
highlighted the prevalence of this, one showing 50,111 overlapping transcript pairs in 
the human genome and another that up to 88% of protein-coding ORFs display 
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concurrent antisense transcription (Katayama et al., 2005, Vallon-Christersson et al., 
2007).  
 The ncRNAs produced from this pervasive transcription can be divided into two 
main classes: short ncRNAs, or long ncRNAs. Short ncRNAs include short-interfering 
RNAs and micro RNAs, which often have trans regulatory roles, related to RNA 
interference in higher eukaryotes (Jacquier, 2009). In yeast the long ncRNAs are 
comprised of two groups: the stable un-annotated transcripts (SUTs) and the cryptic 
unstable transcripts (CUTs). These two classes of ncRNA differ from one another in 
several respects. Firstly, SUTs (as their name would imply) are stable, whereas CUTs 
are rapidly degraded and only detectable in exosome mutants, such as rrp6∆ (Xu et al., 
2009). Secondly, there is a clear difference in length between the two groups: CUTs are 
typically 200-600 nts long and have a heterogeneous 3’ end, whilst SUTs are much 
longer with a median size of 760 nts (Xu et al., 2009). Frequently, CUTs and SUTs are 
found to initiate from nucleosome-free regions (NFRs) associated with promoters and 
3’ regions of genes (Xu et al., 2009, Neil et al., 2009). Strikingly, this was found to be a 
result of the inherent bi-directionality, characteristic of eukaryotic promoters (Xu et al., 
2009, Neil et al., 2009). Therefore, many initiation events result in RNAPII firing in 
both directions away from the promoter, transcribing opposite strands of DNA. 
Additional ncRNA production from 3’NFRs is likely to result from altered chromatin 
structure following gene transcription. In support of this, cells lacking the gene for the 
chromatin remodelling protein Isw2 display increased SUT and CUT production, owing 
to enhanced 3’ nucleosome depletion (Whitehouse et al., 2007). 
 The function of many ncRNAs is, however, unknown, but some studies have 
shown that it is the act of transcribing the ncRNA itself that has a function, in many 
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cases serving to regulate neighbouring genes (Martens et al., 2004, Hongay et al., 2006, 
Xu et al., 2011, Martens et al., 2005). A gene involved in the serine biosynthesis 
pathway, SER3, is subject to this form of cis regulation by a ncRNA, SRG1 (Martens et 
al., 2004). SRG1 is transcribed from upstream of the SER3 promoter, in a tandem 
(sense) orientation to the gene. The act of transcribing SRG1 was shown to occlude the 
SER3 promoter, preventing the binding of activators/initiation factors, and ultimately, 
repressing SER3 expression (Martens et al., 2004).  
 Similarly, the IME4 locus in yeast is also regulated by the production of a 
ncRNA. Expression of the IME4 gene is necessary to commit a cell to meiosis. 
Therefore it is, necessarily, tightly repressed in haploid cells and temporally regulated in 
diploids. Repression of IME4 in haploids was found to result from antisense 
transcription across the gene (Hongay et al., 2006). The diploid-specific a1/ α2 protein 
was shown to be able to bind and inhibit production of the antisense transcript, when 
activation of IME4 is required. The authors suggest that the mechanism of repression by 
the ncRNA could be due to transcriptional interference, either through RNAPII 
interactions or promoter occlusion. In this case, transcription of the antisense ncRNA 
could be providing a mechanism for fine-tuning expression of IME4, ensuring that the 
gene is tightly repressed when necessary. There is likely to be an evolutionary 
advantage to this, as untimely expression of a gene, particularly one committing a cell 
to a developmental fate, could ultimately be fatal. 
 In addition to the repressive role of ncRNA transcription, it has also been shown 
to have an activating function. This is certainly the case at the phosphate biosynthesis 
pathway gene, PHO5. PHO5 was found to have an associated antisense ncRNA, 
transcribed when the gene is in a repressed state (Uhler et al., 2007). This study found 
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that histone eviction at the PHO5 promoter is associated with antisense RNAPII 
transcription, which enhances chromatin plasticity. In support of this mechanism, 
abrogating transcription of the ncRNA led to a delay in both chromatin remodelling and 
RNAPII recruitment to the PHO5 promoter. Therefore, this suggests a role for ncRNA 
transcription at genes that are required to respond rapidly to external cues. Indeed, this 
was found to be the case in a recent genome-wide study from the Steinmetz laboratory 
(Xu et al., 2011). Antisense expression was found at genes with a large expression 
range, i.e. they show high levels of expression when active, and very low levels of 
expression when repressed. Moreover, stress-response and environment-specific genes, 
which are required to respond in a switch-like manner, are characterised by high levels 
of antisense transcription. Altogether, this suggests that ncRNA, and especially 
antisense ncRNA, can serve to regulate genes by a variety of methods. 
 Altogether, numerous recent studies indicate that transcription is surprisingly 
pervasive and that the transcriptional landscape is highly dynamic and inter-regulated. 
The orientation and spatial arrangement of genes has an impact on their expression, 
whilst the abundance of ncRNAs, and specifically the act of transcribing them, suggests 
that they are important for gene regulation. Furthermore, it highlights a gap in our 
knowledge of ncRNA production, at the level of transcript elongation. 
1.6 Aims and scope of this thesis 
1.6.1 Relevant background 
 There has been very little research into gene traffic and progression of RNAPII 
on busy coding regions, where multiple DNA metabolic events are occurring con-
currently. The usual reductionist methods tend to treat transcription in isolation, but it is 
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affected by and affects other events occurring on DNA, possibly the best-studied being 
the interactions between transcription and replication machineries (Pomerantz and 
O'Donnell, 2008, Pomerantz and O'Donnell, 2010), or between transcription and DNA 
repair (Selth et al., 2010). Studying transcript elongation in the context of other DNA 
events is important to gain a more comprehensive understanding of the process in vivo. 
Recent research in the Svejstrup laboratory has contributed to the study of gene 
traffic by analysing interactions between tandemly transcribing RNAPII molecules, 
mimicking events occurring on highly transcribed genes (Saeki and Svejstrup, 2009). 
The findings of the study were numerous and far-reaching, yielding mechanistic and 
conceptual insights, with implications for the processivity of transcription in vivo. The 
experiments were all performed with a highly purified RNAPII scaffold system 
allowing reconstitution of transcription with two polymerases transcribing in the same 
direction using pure RNAPII, DNA- and RNA oligonculeotides. The results obtained 
showed that RNAPII is conformationally flexible so that when a leading EC was stalled 
on DNA (mimicking arrest at a damage site or other elongation impediment) the trailing 
RNAPII substantially invaded the space of the leading polymerase, ultimately resulting 
in significant backtracking of the trailing RNAPII molecule upon collision. Most 
interestingly, when the leading RNAPII was paused at a poly-A/T tract, the trailing 
RNAPII was able to push the former through the transcription block. This finding has 
important implications for our understanding of elongation in vivo and suggests that 
tandemly transcribing RNAPIIs are able to confer increased processivity on each other 
in the face of transcriptional pauses. The latter findings are also consistent with those 
observed for prokaryotic RNAP (Epshtein and Nudler, 2003). 
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While the studies described above focused on head-to-tail transcription, little is 
known about convergent transcription (head-to-head collision) and its mechanistic basis. 
The finding that RNAPII produces numerous antisense, non-coding RNAs, raises 
important questions when considering their production. The transcription of antisense 
RNAs often occurs from 3’ ends of active genes and most yeast promoters are bi-
directional (Neil et al., 2009). This would undoubtedly lead to interactions between 
promoter-driven ECs and ECs originating from 3’ cryptic initiation events. Likewise, 
interactions would occur between RNAPII terminating at the 3’ end of tandem genes 
and bi-directional transcripts originating from downstream promoters. However, 
undoubtedly the largest source of RNAPII interactions would be between convergent 
genes, which in many cases have no terminator (and/or only a very short distance) 
between them. 
 Convergent transcription was the subject of a recent biochemical study using T3 
and T7 bacteriophage polymerases (Ma and McAllister, 2009). The main finding was 
that a T7 polymerase can bypass a T3 polymerase stalled on the DNA template and that 
following this, the T3 polymerase is able to continue transcription. The authors suggest 
that there is a temporary release of the NTS from the colliding polymerases, allowing 
transcriptional bypass. The findings of this study have important implications for 
convergent transcription in eukaryotes, in which the core of polymerase and its nucleic 
acid interactions may be similar (Durniak et al., 2008, Cramer et al., 2001, Gnatt et al., 
2001). From a nucleic acid-centric perspective there should thus be no impediment to 
bypass, which in theory requires only a widening of the transcription bubble (Figure 
1.5A). However, this is more difficult to envisage when looking at a structure of the 
elongation complex, with RNAPII being of significant size and structural complexity  





Figure 1.5 Representations of convergent transcription. 
A. Schematic showing nucleic-acid centric view of transcription. Bypass could occur by 
widening of the transcription bubble. B. Protein-centric view of elongation, showing a 
crystallographic model of convergently transcribing RNAPII molecules (Gnatt et al., 2001). 
DNA (blue and green) and RNA (red) are represented. 
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(Figure 1.5B). This is in stark contrast to the single-subunit bacteriophage polymerases, 
which are much smaller and share only the conserved core, lacking the outer protein 
density (Durniak et al., 2008). Interestingly, this may be an indication that interactions 
between convergent polymerases could be very different in the two systems. 
In support of a difference between bacteriophage RNAP and eukaryotic RNAPII, 
an in vivo study from the Proudfoot laboratory found that GAL genes orientated 
convergently without terminators between them produced only truncated transcripts and 
showed a severe reduction in steady-state RNA levels, presumably at least partly as a 
result of RNAPII collision (Prescott and Proudfoot, 2002). Additionally, control 
constructs arranged in a tandem orientation did not result in reduced RNA levels, 
arguing against RNA-interference effects. However, a limitation of this study was the 
inability to distinguish between promoter occlusion and elongation effects arising from 
convergent transcription. For a better understanding of convergent transcription, it 
needs to be studied mechanistically, both in vivo and in vitro, at the level of transcript 
elongation. 
1.6.2 Objectives of this work 
 There is a distinct lack of understanding concerning the fundamental nature of 
convergent transcription. This shortfall is highlighted in the literature (see section 1.5). 
Numerous studies discuss the production of antisense ncRNA, which is undoubtedly, in 
some cases, transcribed concurrently with sense gene mRNA (Vallon-Christersson et al., 
2007). Additionally, the presence of overlapping convergent transcription units and 
nested genes are acknowledged (see section 1.5.1). However, no studies have addressed 
the mechanistic basis of this convergent transcription at the level of RNAPII elongation 
and surprisingly, none have attempted to address the absolutely fundamental question: 
Chapter 1 Introduction 
 64 
can convergently transcribing RNAPII molecules transcribe past one another? Either 
answer to this question will necessarily yield exciting new insights into transcript 
elongation on busy genomic regions. If RNAPII cannot bypass then what happens to the 
collided polymerases? If it can bypass, then by what mechanism? What effect does this 
event have on sense-antisense transcription, or transcription at convergent gene pairs? 
 This thesis aims to address these issues: firstly by utilising an in vitro 
biochemical assay to determine the outcome of RNAPII convergent transcription and 
then building upon these findings in vivo with a convergent gene construct and later 
genome-wide studies. The data acquired in each system fully complements one another 
and has provided insight into the outcome of RNAPII convergent transcription, with 
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Chapter 2. Materials & Methods 
2.1 Buffers, media and solutions 
2.1.1 Yeast media 
2.1.1.1 YPD 
• 1% Yeast Extract (DIFCO) 
• 1% Peptone (DIFCO) 
• 2% Glucose 
Supplemented with adenine to a final concentration of 40 µg/ml. 
2.1.1.2 Synthetic Complete Medium 
• 2% Glucose or raffinose 
• 6.7 mg/ml Yeast Nitrogen Base (DIFCO) 
• 1.4 mg/ml Yeast Synthetic Drop-out Medium Supplement without Histidine, 
Leucine, Tryptophan and Uracil (Sigma) 
• 40 µg/ml Tryptophan 
• 40 µg/ml Histidine 
• 80 µg/ml Leucine 
• 40 µg/ml Uracil 
• 24 µg/ml Adenine 
To make media selective for yeast carrying a marker gene required for its synthesis, that 
particular amino acid was left out of the mixture. Selective plates were made in the 
same way, except that water was replaced with 1.6% agar. 
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2.1.2 Bacterial media 
2.1.2.1 LB (rich medium) 
• 1% Bacto Tryptone (DIFCO) 
• 0.5% Yeast Extract (DIFCO) 
• 1% NaCl 
pH adjusted to 7. 
• -/+ 100 µg/ml Ampicillin (Melford Laboratories) 
2.1.2.2 SOC (heat-shock recovery medium) 
• 2 % Bacto Tryptone (DIFCO) 
• 0.5% Yeast Extract (DIFCO) 
• 10 mM NaCl 
• 2.5 mM KCl 
• 10 mM MgCl2 
• 10 mM MgSO4 
• 20 mM Glucose 
pH adjusted to 7. 
2.1.3 General solutions 
2.1.3.1 PBS (phosphate-buffered saline) 
• 130 mM NaCl 
• 7 mM Na2HPO4  
• 2 mM NaH2PO4 
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Adjusted to pH 7.5. 
2.1.3.2 TBS (Tris-buffered saline) 
• 50 mM Tris-Cl (pH 7.6) 
• 150 mM NaCl 
2.1.3.3 TE (Tris-EDTA) 
• 10 mM Tris-Cl pH 7.5 
• 1 mM EDTA pH 8.0 
This was also made up as a 10 x solution. 
2.1.3.4 TE low EDTA 
• 10 mM Tris-Cl pH 7.5 
• 0.1 mM EDTA pH 8.0  
2.1.3.5 TBE (Tris-Borate-EDTA) 
• 89 mM Tris Base 
• 89 mM Boric Acid 
• 2 mM EDTA 
2.1.3.6 TE/LiOAc 
• 1 x TE pH 7.5 
• 100 mM Lithium acetate 




• 1 x TE pH 7.5 
• 100 mM Lithium acetate 
• 50% PEG (3350) 
2.1.3.8 10 x Agarose gel DNA loading Buffer 
• 20 mM EDTA pH 8.0 
• 50% Glycerol 
• 0.05% Bromophenol blue 
2.1.3.9 5x SDS-PAGE loading buffer 
• 250 mM Tris-Cl pH 6.8 
• 500 mM DTT 
• 10% SDS 
• 0.5% Bromophenol blue 
• 50% Glycerol 
2.1.3.10 Denaturing PAGE loading buffer 
• 95% De-ionised formamide (Sigma) 
• 5 mM EDTA pH 8.0 
• 0.004% Bromophenol blue 
• 0.004% Xylene cyanol 
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2.1.3.11 100 x Protease inhibitor cocktail 
• 28.4 µg/ml Leupeptin 
• 137 µg/ml Pepstatin A 
• 17 µg/ml PMSF 
• 33 µg/ml Benzamidine 
All components dissolved in 100% ethanol. 
2.1.4 Buffers for RNAPII purification 
2.1.4.1 Yeast Lysis Buffer 
• 50 mM Tris-Cl (pH 8.0) 
• 150 mM KCl 
• 10% Glycerol 
• 10 µM ZnCl2 
• 1 mM EDTA  
• 10 mM DTT 
• 1 x Protease inhibitors 
2.1.4.2 HSB150 (Heparin sulphate chromatography) 
• 50 mM Tris-Cl (pH 8.0) 
• 150 mM KCl 
• 1 mM EDTA  
• 10% Glycerol 
• 10 mM DTT 
Chapter 2 Materials and Methods 
 
 70 
• 10 µM ZnCl2 
• 1 x Protease inhibitors 
2.1.4.3 HSB600 
• 50 mM Tris-Cl (pH 8.0) 
• 600 mM KCl 
• 1 mM EDTA  
• 10% Glycerol 
• 10 mM DTT 
• 10 µM ZnCl2 
• 1 x Protease inhibitors 
2.1.4.4 TEZ0 
• 50 mM Tris-Cl pH 7.5 
• 1 mM EDTA  
• 10 µM ZnCl2 
• 10 mM DTT 
• 1 x Protease inhibitors 
2.1.4.5 TEZ500 
• 50 mM Tris-Cl pH 7.5 
• 500 mM Ammonium sulphate 
• 1 mM EDTA  
• 10 µM ZnCl2 
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• 10mM DTT 
• 1 x Protease inhibitors 
2.1.4.6 TEZElution 
• 50 mM Tris-Cl pH 7.5 
• 500 mM Ammonium sulphate 
• 50% Glycerol 
• 1 mM EDTA  
• 10 µM ZnCl2 
• 10 mM DTT 
• 1 x Protease inhibitors 
2.1.4.7 MonoQ Dilution Buffer 
• 50 mM Tris-Cl pH 7.5 
• 10% Glycerol 
• 0.5 mM EDTA  
• 10 µM ZnCl2 
• 5 mM DTT 
• 1 x Protease inhibitors 
2.1.4.8 MonoQ200 
• 50 mM Tris-Cl pH 7.5 
• 200 mM KCl 
• 10% Glycerol 
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• 0.5 mM EDTA  
• 10 µM ZnCl2 
• 5 mM DTT 
• 1 x Protease inhibitors 
2.1.4.9 MonoQ1000 
• 50 mM Tris-Cl pH 7.5 
• 1 M KCl 
• 10% Glycerol 
• 0.5 mM EDTA  
• 10 µM ZnCl2 
• 5 mM DTT 
• 1 x Protease inhibitors 
2.1.4.10 RNAPII Buffer 
• 20 mM HEPES-KOH pH7.6 
• 100 mM KOAc 
• 0.1 mM EDTA 
• 10% Glycerol 
• 2 mM DTT 
• 0.1 mM PMSF 
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2.1.5 Buffers for reconstitution and analysis of elongation in vitro 
2.1.5.1 Reconstitution Buffer 
• 20 mM Tris-Cl (pH 7.9) 
• 40 mM KCl 
• 0.2 mM MgCl2 
• 20 µM ZnCl2 
• 5 mM DTT 
2.1.5.2 Transcription Buffer 
• 20 mM Tris-Cl (pH 7.9) 
• 40 mM KCl 
• 7 mM MgCl2 
• 20 µM ZnCl2 
• 5 mM DTT 
• 0.75 mg/ml BSA (NEB) 
2.1.5.3 EC Wash Buffer 
• 50 mM Tris-Cl pH 7.5 
• 500 mM NaCl 
• 0.5 mM EDTA  
• 10 µM ZnCl2 
• 0.05% NP-40 
• 10% Glycerol 




The same recipe as transcription buffer but with 300 µg/ml FLAG peptide added. 
2.1.5.5 Stop Buffer 
• 20 mM Tris pH7.9 
• 40 mM KCl 
• 20 µM ZnCl2 
• 5 mM DTT  
• 20 mM EDTA 
• -/+ 1 mg/ml Proteinase K 
2.1.5.6 Native agarose loading buffer 
• 3% Glycerol 
• 0.75 mg/ml BSA (NEB) 
• 2.5 mM 2-mercaptoethanol 
2.1.5.7 Native agarose gel 
• 0.7% NuSieve GTG Agarose (Lonza) 
• 22.25 mM Tris base 
• 22.25 mM Boric acid 
• 5 mM 2-mercaptoethanol 
• 0.1 mM MgCl2 
• 10 µM ZnCl2 
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2.1.5.8 Urea denaturing PAGE 
• 1 x TBE  
• 8.3 M Urea 
• 0.07% TEMED 
• 0.05% APS 
The correct percentage gel was prepared by adding 40% Acrylamide/Bis Solution 
(19:1) (BioRad). 
2.1.6 Buffers for analysis of transcription in vivo 
2.1.6.1 Buffer Y1 
• 1 M Sorbitol 
• 100 mM EDTA pH 7.4 
2.1.6.2 Spheroplasting buffer 
• Buffer Y1 
• 0.1% 2-mercaptoethanol 
• 100 U Zymolase-20T (MP Biomedicals) 
2.1.7 Buffers for ChIP 
2.1.7.1 FA-Lysis 
• 50 mM Tris-Cl (pH 7.5) 
• 140 mM NaCl 
• 1 mM EDTA  
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• 1% Triton X-100 
• 0.1% Na-deoxycholate 
2.1.7.2 FA-500 
• 50 mM Tris-Cl (pH 7.5) 
• 500 mM NaCl 
• 1 mM EDTA  
• 1% Triton X-100 
• 0.1% Na-deoxycholate 
2.1.7.3 ChIP-WB 
• 10 mM Tris-Cl (pH 8.0) 
• 250 mM LiCl 
• 0.5% NP-40 
• 1 mM EDTA  
• 0.5% Na-deoxycholate 
2.1.7.4 TES 
• 10 mM Tris-Cl (pH 7.5) 
• 1mM EDTA 
• 100 mM NaCl 
2.1.7.5 ChIP-Elution 
• 50 mM Tris-Cl (pH 8.0) 
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• 10 mM EDTA 
• 1% SDS 
2.2 Bacterial techniques 
2.2.1 Transformation of chemically-competent E. coli 
 TOP10 cells (Invitrogen) were used for transformations with plasmid and 
newly-ligated DNA. Typically 200 ng of plasmid DNA or 2 µl of ligation mixture were 
added to bacteria and incubated for 5 minutes on ice prior to heat-shocking for 30 
seconds at 42 °C. Cells were placed on ice to recover and 250 µl of SOC medium (see 
section 2.1.2.2) added. Cells were incubated at 37 °C with shaking and plated onto pre-
warmed LB-Amp plates. 
2.2.2 Plasmid mini-prep 
 Typically 2 ml bacterial cultures were grown in LB-Amp (see section 2.1.2.1) 
liquid culture overnight at 37 °C and plasmid DNA extracted using QIAprep Miniprep 
Kit (QIAGEN) following standard procedures. 
2.2.3 Expression of recombinant proteins 
 Bacteria carrying a plasmid for protein expression were grown in LB-Amp to an 
OD600 density of 0.7, 1mM IPTG added and transferred to a 30 °C incubator for 3 hours 
to induce protein expression. Bacteria were harvested by centrifugation and lysed by 
sonication. 
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2.3 DNA techniques 
2.3.1 Polymerase Chain Reaction (PCR) 
 PCRs were performed using the KOD Hot Start DNA Polymerase Kit 
(Novagen) following standard cycling procedures. A typical PCR reaction was set up as 
follows: 
• 1x KOD reaction buffer 
• 1.5 mM MgSO4 
• 0.2 mM dNTPs 
• 0.3 µM Sense primer 
• 0.3 µM Antisense primer 
• 0.22 ng/µl Template DNA 
• 0.02 U/µl KOD Hot Start DNA Polymerase 
2.3.2 Quantitative PCR (qPCR) 
 qPCR reactions were prepared in a 20 µl reaction volume as follows: 
• 1 x iQ Custom SYBR Green SuperMix (BioRad) 
• 0.2 µM Sense primer 
• 0.2 µM Antisense primer 
• µl DNA (from ChIP) 
The reactions were then placed in a CFX-96 Real-Time System (BioRad) and standard 
cycling conditions used. 
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2.3.3 Restriction digestion 
 Restriction digests were performed with enzymes obtained from NEB and 
generally the reaction was allowed to continue overnight at 37 °C. The following 
reaction mixture is typical: 
• 1 x NEB reaction buffer (1-4 dependent on enzyme used) 
• 1 µg DNA 
• 1 µl Restriction enzyme 
• 1 µl Restriction enzyme 2 (optional) 
• dH2O added up to 50 µl 
2.3.4 DNA ligations 
 DNA ligations were usually set up in a volume of 10 µl with 100 ng of vector, a 
3 times molar excess of insert, 1 x reaction buffer (Roche) and 1 µl T4 DNA ligase 
(Roche). The reaction was allowed to proceed for 1 hour at 25 °C prior to 
transformation. 
2.3.5 DNA purification 
 Typically DNA was purified following PCR, restriction digest and ChIP using 
QIAquick PCR Purification Kit (QIAGEN) following the manufacturers 
recommendations. In the case of ChIP DNA purification, standard procedures were 
followed but DNA was eluted from the column with 100 µl of nuclease-free dH2O. 
Chapter 2 Materials and Methods 
 
 80 
2.3.6 Sequencing of plasmid DNA 
 Plasmid DNA was sequenced at the Cancer Research UK Sequencing Facility 
using standard methods. 20 µl sequencing reactions were set up as follows: 
• 3 µl BigDye Terminator 5x Sequncing Buffer (Applied Biosystems) 
• 2 µl BigDye Terminator (Applied Biosystems)  
• 0.64 µl Primer (3.2 pmol final concentration) 
• 200 ng Plasmid DNA 
The reaction took place in a thermal cycler, using the conditions indicated (Table 2.1). 
Table 2.1 Cycling conditions used during the sequencing reaction. 
STEP NUMBER TEMPEARATURE (°C) TIME 
1 96 1 minute 
2 96 10 seconds 
3 50 5 seconds 
4 60 4 minutes 
GO TO STEP 2 (x 25) 
5 4 Forever 
 
2.3.7 De-proteinisation of DNA 
 DNA solution was mixed with an equal volume of Phenol:Chloroform:Isoamyl 
Alcohol (25:24:1) saturated with 10 mM Tris-Cl pH 8.0, 1mM EDTA (Sigma) and 
isolated using MaXtract High Density phase-lock tubes (QIAGEN) following the 
manufacturer’s recommendations. 
2.3.8 Ethanol precipitation of DNA 
 DNA was ethanol-precipitated by adding 300 mM NaOAc (pH 5.2), -/+ 5 µg 
glycogen and 2 times volume of ice-cold absolute ethanol. The mixture was placed at 
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minus 20 °C overnight prior to centrifugation and removal of supernatant. Pellets were 
washed with 70% ethanol and resuspended in TE (see section 2.1.3.3). 
2.3.9 De-salting of DNA 
 DNA desalting was performed using MicroSpin G-25 columns (GE Healthcare) 
following the manufacturer’s recommendations. 
2.3.10 Standard agarose gel electrophoresis 
 Horizontal agarose gel electrophoresis was used to separate DNA of different 
sizes. The agarose content was dependent on the size of fragments being resolved, with 
0.7-2% commonly used. Agarose was added to 1 x TBE (see section 2.1.3.5) and heated 
until dissolved. Once cool, ethidium bromide (Sigma) was added to a final 
concentration of 0.5 µg/ml and the gel poured. DNA in 1 x Agarose gel DNA loading 
buffer (see section 2.1.3.8) was loaded into the wells. The buffer for electrophoresis was 
1 x TBE and the voltage used typically 100 V.  
2.3.11 Purification of DNA from agarose gels 
 DNA was visualised on a UV transilluminator and a scalpel used to isolate the 
appropriate DNA band. QIAquick Gel Extraction Kit (QIAGEN) and standard protocols 
were used to extract the DNA from the agarose. 
2.3.12 32P-end labelling of DNA oligonucleotides 
 DNA oligonucleotides were 5’ end-labelled using 32P-γATP in the following 
reaction mixture: 
• 20 pmol DNA 
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• 1 x T4 polynucleotide kinase buffer (NEB) 
• 63 µCi 32P-γATP (Perkin-Elmer) 
• 10 U T4 polynucleotide kinase (NEB) 
The reaction was allowed to proceed at 37 °C for 30 minutes, then another 10 U of T4 
polynucleotide kinase added for another 30 minutes at 37 °C. The reaction was stopped 
by the addition of EDTA to a final concentration of 20 mM and deproteinised by 
phenol-chloroform extraction (see section 2.3.7). Unincorporated 32P-γATP was 
removed by G-25 de-salting column (see section 2.3.9) followed by ethanol 
precipitation (see section 2.3.8), this process was repeated and 32P-end labelled DNA 
resuspended in TE low EDTA (see section 2.1.3.4). 
2.3.13 Purification of DNA oligonucleotides via denaturing PAGE 
 Full-length DNA oligonucleotides were purified from shorter intermediates of 
incomplete synthesis using denaturing PAGE. A 5.2% urea polyacrylamide gel was 
placed in the Sequi-Gen GT Sequencing Cell (BioRad) and used to resolve DNA, which 
was visualised by UV-shadowing and isolated with a scalpel. The gel slice was 
macerated and eluted using TE at 25 °C overnight, followed by a second elution at 
37 °C for 3 hours. The two eluates were pooled and passed twice through 0.2 µm 
NANOSEP MF filtration columns (Pall). The DNA solution was then concentrated by 
butanol extraction (using standard techniques) followed by phenol-chloroform 
extraction (see section 2.3.7) and ethanol precipitation (- glycogen) (see section 2.3.8). 
DNA was finally de-salted (see section 2.3.9) and subjected to another round of ethanol 
precipitation and resuspension in TE low EDTA (see section 2.1.3.4). 
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 To test the purity of the isolated DNA oligonucleotide, it was 32P-end labelled 
(see section 2.3.12) and resolved by 5.2% denaturing PAGE. 
2.4 RNA techniques 
2.4.1 Extraction of total RNA from yeast cells 
 Yeast cells were grown to mid-log phase and where necessary, galactose or 
glucose added. Cells were harvested and washed in ice-cold TBS prior to resuspension 
in spheroplasting solution (see section 2.1.6.2) for 10 minutes at 30 °C with agitation. 
Spheroplasts were lysed and RNA extracted using the RNeasy Kit (QIAGEN) following 
the manufacturer’s recommendations. 
2.4.2 De-proteinisation of RNA 
 De-proteinisation of RNA was performed in the same manner as for DNA (see 
section 2.3.7). 
2.4.3 Ethanol precipitation of RNA 
 RNA was precipitated by the addition of 3 M NaOAc pH 5.2 to a final 
concentration of 300 mM, -/+ 5 µg glycogen and 3 times volume of ice-cold absolute 
ethanol. Samples were incubated at -20 °C overnight prior to centrifugation and 
washing twice with 80% ethanol. Finally, pellets were resuspended in TE low EDTA 
(see section 2.1.3.4) or for direct analysism in formamide gel loading buffer (see section 
2.1.3.10). 
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2.4.4 32P-end labelling of RNA oligonucleotides 
 RNA oligonucleotides were 32P-end labelled in the same manner as DNA 
oligonucleotides (see section 2.3.12), however, the ethanol precipitation was carried out 
as outlined for RNA (see section 2.4.3). 
2.4.5 Purification of RNA oligonucleotides via denaturing PAGE 
 RNA oligonucleotides were purified in a manner similar to DNA 
oligonucleotides (see section 2.3.13), except that electrophoresis was on a 20% 
denaturing gel and ethanol precipitation was performed as outlined for RNA (see 
section 2.4.3). 
2.5 Yeast techniques 
2.5.1 Yeast strains used in this study 
 All in vivo experiments were performed with S. cerevisiae strains congenic to 
W303 (Thomas and Rothstein, 1989) and include elc1Δ::URA3 and def1∆::URA3 
(Harreman et al., 2009, Woudstra et al., 2002), full details of the strains are listed below 
(Table 2.2). 
Table 2.2 Yeast strains used in this study. 
STRAIN GENOTYPE 
W303-1A 
MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-
100 
W303-1B 
MATα leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 
can1-100 
elc1∆ 
MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-
100 elc1∆::URA3 
def1∆ 
MATa leu2-3,112 his3-11,15 ade2-1 ura3-1 trp1-1 can1-
100 def1∆::URA3 
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2.5.2 Conditions for culturing yeast 
 Starter cultures of yeast were set up in 5 ml of YPD (see section 2.1.1.1) and 
grown overnight at 30 °C to stationary phase. Cells were typically diluted in the 
morning to 2 x 106 cells/ml.  
 In the case of yeast harbouring the pRS314-GAL10-GAL7 or pRS314-GAL10-
GAL7∆TATA plasmids, cells were grown for 24 hours in synthetic complete media (see 
section 2.1.1.2) lacking tryptophan and with raffinose as the only sugar source. Cells 
were then diluted to approximately 2 x 106 cells/ml and grown to mid-log phase where 
2% glucose or galactose was added for the indicated time prior to harvesting or 
crosslinking. 
2.5.3 Lithium-acetate transformations 
 Yeast cultures were set up in 5 ml of YPD (see section 2.1.1.1) and grown 
overnight at 30 °C to stationary phase. Cells were diluted in YPD to a concentration of 
2 x 106 cells/ml in a total volume of 50 ml and grown to mid-log phase, before being 
centrifuged and washed twice in distilled water. The yeast pellets were washed in 1 ml 
of TE/LiOAc (see section 2.1.3.6) prior to resuspension in 500 µl of TE/LiOAc. 100 µl 
of yeast suspension (1 x 108 cells/ml) was used per transformation, to which was added 
100 ng of plasmid DNA, 50 µg of salmon-sperm DNA (which was boiled for 3 minutes 
and placed on ice before adding) and 600 µl of PEG/TE/LiOAc (see section 2.1.3.7). A 
control transformation was always performed, where TE rather than plasmid DNA was 
added. Transformation mixtures were placed in a 30 °C incubator for 30 minutes and 
once removed 70 µl of DMSO was added and heat-shock performed at 42 °C for 15 
minutes. Lastly, samples were centrifuged and the supernatant discarded prior to 
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washing in distilled water and plating onto the appropriate selective media (see section 
2.1.1.2). 
2.5.4 Preparing yeast extracts 
 Yeast cultures were pelleted and washed twice in TBS (see section 2.1.3.2) and 
washed in 1 ml of FA-lysis buffer (see section 2.1.7.1) prior to resuspension in 700 µl 
of FA-lysis buffer and addition of 0.5 mm Zirconia/Silica Beads (BioSpec Products, 
Inc.). Lysis of cells was performed in a FastPrep-24 Tissue and Cell Homogenizer (MP 
Biomedicals) with the following conditions: level 5.5 for 30 seconds, with cooling on 
ice for 1 minute, repeated 6 times. 
2.6 Protein techniques 
2.6.1 SDS-PAGE 
 Precast 4-12% Bis-Tris gradient gels (Biorad) were routinely used to separate 
proteins. The running buffer was XT MES buffer (Biorad) and electrophoresis was 
carried out in Criterion chambers (Biorad). The Precision Plus protein marker from 
Biorad was used to determine the size of the detected protein. For analysis of RNAPII 
4-12 % gradient gels were usually run at 180 V for 45 minutes and protein detected by 
staining with InstantBlue (Expedeon), according to the manufacturer’s instructions. 
2.6.2 Western-blotting 
 Following electrophoresis of proteins by SDS-PAGE, gels were briefly washed 
in water before soaking in transfer buffer (25 mM Tris, 60 mM Glycine, 20% Methanol). 
Hybond C-Extra membrane (Amersham Biosicences) was placed on top of the gel and 
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sandwiched between two pieces of Whatman 3MM paper. This was then placed in a 
Biorad Criterion Blotter and transferred (in transfer buffer) at 4 °C for 90 minutes at 
500 mA. The membrane was then incubated with PBS (see section 2.1.3.1) +2% milk 
powder (Marvel) for 30 minutes at 25 °C. 
2.6.3 Detection of blotted proteins 
 Blotted proteins were detected using a primary antibody against the protein of 
interest, or against an epitope tag on the protein. Typically 1:10,000 dilution of antibody 
(for detecting Rpb1 of RNAPII) in PBS +2% milk was incubated with the blot for 2 
hours at 25 °C. The blot was then washed 3 times 10 minutes in PBS. Next a 1:10,000 
dilution of secondary antibody (with conjugated HRP) in PBS +2 % milk was added for 
1 hour at 25 °C, again followed by 3 times 10 minute washes in PBS. The binding of 
primary and secondary antibody was detected using a SuperSignal West Pico 
Chemiluminescent Substrate kit (Thermo Scientific) and exposure of the membrane to 
Amersham Hyperfilm ECL (GE Healthcare). 
2.6.4 RNA polymerase II purification 
 RNAPII purification was carried out based on a previously developed protocol 
(Cramer et al., 2001). 100 L of yeast cells were grown to a high density and harvested. 
Cells were lysed by ball-milling and the extract cleared by centrifugation. Extract was 
loaded at 5 ml/minute onto a 350 ml heparin-sulphate column, equilibrated with 
HSB150 (see section 2.1.4.2). 3 column volumes (CV) of HSB150 were pumped 
through the column to remove non-specifically bound proteins. Protein was eluted by 
addition of HSB600 (see section 2.1.4.3). Collected fractions were pooled and placed in 
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a container with a magnetic stirrer. Ammonium sulphate powder was added in 20 g 
amounts with 15 minutes between each addition, until a saturation of 50 % had been 
achieved. The solution was centrifuged in a GSA rotor at 12000 rpm for 20 minutes and 
the supernatant discarded. A second spin was performed at 10,000 rpm for 15 minutes 
to ensure any remaining supernatant was removed. 
 The pellet obtained from ammonium sulphate precipitation was resuspended in 
TEZ0 (see section 2.1.4.4) in a volume of 20 ml and the conductivity checked against 
TEZ500 (see section 2.1.4.5) to determine if more TEZ0 should be added. Once the 
conductivity was similar to that of TEZ500, the sample was mixed with 4 ml of 8WG16-
agarose resin and bound in batch for 2 hours at 4 °C. The protein-resin slurry was 
poured into a column and washed under gravity with 10 CV of TEZ500. Another 10 CV 
TEZ500 wash was performed at 25 °C prior to elution with TEZElution (see section 
2.1.4.6) at 25 °C and collection of 1.5 ml fractions. Samples were taken from each 
fraction and SDS-PAGE loading buffer (see section 2.1.3.9) added prior to SDS-PAGE 
of the samples (see section 2.6.1). Peak fractions were pooled and diluted in 3 times 
volume of MonoQ Dilution Buffer (see section 2.1.4.7) and loaded onto a 1ml MonoQ 
column at a rate of 0.5 ml/minute. A gradient was set up from 200 mM KCl in 
MonoQ200 (see section 2.1.4.8) to 1M KCl in MonoQ1000 (see section 2.1.4.9) and 1 
ml fractions collected. Fractions were analysed by SDS-PAGE to determine the purity 
of isolated RNAPII. Fractions containing pure RNAPII were dialysed into RNAPII 
Buffer (see section 2.1.4.10) 
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2.6.5 Purification of recombinant TFIIS 
E. coli BL21-CodonPlus (DE3) RIL strain (Agilent) was transformed with 
pET15b-DST1 (see section 2.2.1), grown in LB containing ampicillin and 
chloramphenicol to an OD600 of 0.7 and protein expression induced by the addition of 1 
mM IPTG at 37 °C for 3.5 hours. Harvested cells were resuspended in CBB (50 mM 
KH2PO4 pH 8.0, 300 mM NaCl, 10 mM Imidazole, 1 mM 2-mercaptoethanol and 1 x 
PIs) and sonicated. Binding of His-tagged protein to Ni-NTA Agarose (QIAGEN) was 
performed in batch for 2 hours at 4 °C, prior to 30 CV wash with Ni300 (50 mM 
KH2PO4 pH 8.0, 300 mM NaCl, 20 mM imidazole, 1 mM 2-mercaptoethanol, 1 x PIs) 
and 5 CV wash with Ni150 (50 mM KH2PO4 pH 8.0, 150 mM NaCl, 30 mM imidazole, 
1 mM 2-mercaptoethanol, 1 x PIs). Elution buffer (50 mM KH2PO4 pH 8.0, 150 mM 
NaCl, 250 mM imidazole, 1 mM 2-mercaptoethanol, 1 x PIs) was added and 1.5 ml 
fractions collected. Fractions containing recombinant TFIIS were dialysed into 
Transcription Buffer (see section 2.1.5.2). 
2.7 Reconstitution of elongation complexes and transcription 
in vitro 
2.7.1 Reconstitution of elongation complexes 
 Elongation complexes were reconstituted using 150 nucleotide DNA 
oligonucleotides from DNA technology and 9 nt RNA oligonucleotides purchased from 
Dharmacon, the sequences of which are shown (Table 2.3). The DNA oligonucleotides 
were received HPLC purified, but subjected to further purification by 5.2% denaturing 
PAGE (see section 2.3.13), whilst the RNA oligonucleotides were purified by 20% 
denaturing PAGE (see section 2.4.5). 
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 Mono-ECs were assembled in Reconstitution Buffer (see section 2.1.5.1) by 
incubating 1 pmol of TS with 2 pmol of RNA1 (including 400 counts per second (CPS) 
of 32P end-labelled RNA1) at 65 °C for 5 minutes followed by step-wise cooling to 25 
°C over a 40-minute period. 3 pmol of FLAG-tagged RNAPII was added for 25 minutes 
at 25 °C, followed by the addition of 6 pmol of NTS (which was placed at 65 °C for 5 
minutes then stored on ice before addition) at 37 °C for 10 minutes. 
 Di-ECs were formed using the same hybridisation temperatures and times as 
mono-ECs by incubation of 1 pmol of TS with 2 pmol of RNA1 (including 400 CPS 32P 
end-labeled RNA1) followed by addition of 3 pmol of FLAG-tagged RNAPII 
(designated 32P-RNA1-EC) whilst in a separate tube 6 pmol of NTS was incubated with 
12 pmol of unlabelled RNA2 and then 18 pmol of HA-tagged RNAPII (RNA2-EC). 
32P-RNA1-EC and RNA2-EC were mixed and incubated at 37 °C for 10 minutes to 
allow hybridisation to occur. 
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2.7.2 Purification of elongation complexes 
 Mono- and di-ECs were incubated with Anti-FLAG M2 Affinity Gel (Sigma) 
for 1 hour at 4°C with shaking, prior to washing with EC Wash Buffer (see section 
2.1.5.3) and 20 mM Tris-Cl, pH 7.5, followed by elution with FLAG-EB (see section 
2.1.5.4). Purified ECs were then incubated with Anti-HA Affinity Matrix (Roche) for 1 
hour at 4 °C with shaking to isolate di-ECs, followed by repeated washes with EC Wash 
Buffer and 20mM Tris-Cl, pH 7.5. 
2.7.3 Ubiquitylation of elongation complexes 
 Unpurified ECs were incubated with yeast Uba1, Ubc5 and Rsp5 -/+ ubiquitin 
(with all lysine residues mutated) for 90 minutes at 30 °C prior to transcription. 
Ubiquitylation efficiency was assayed by Western blot with 4H8 Rpb1-CTD antibody. 
2.7.4 Transcription and analysis 
 Elongation complexes in Transcription Buffer (see section 2.1.5.2) were 
incubated with 600 µM NTPs (either AUC or AUCG) for 5 minutes at 25 °C (or as 
specified). Transcription was stopped with Stop Buffer (see section 2.1.5.5), and, if 
proteinase K was added, incubated at 37 °C for 30 minutes. Samples were either 
phenol-chloroform extracted (see section 2.4.2) and RNA ethanol precipitated (see 
section 2.4.3) for analysis of transcripts by 8.3 M urea denaturing PAGE (6% 
acrylamide) (see section 2.1.5.8), or elongation complexes analysed by 0.7% agarose 
gel electrophoresis (see section 2.1.5.7) in native agarose loading buffer (see section 
2.1.5.6). 
 Purification of nascent RNA from the agarose gel was performed by staining in 
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a 1:10,000 dilution of Sybr Gold, allowing visualization and excision of the band 
corresponding to the mono- or di-EC, followed by maceration, phenol-chloroform 
extraction (see section 2.4.2), butanol extraction and ethanol precipitation (see section 
2.4.3). Transcripts were then analysed by denaturing PAGE (see section 2.1.5.8) and 
exposure to phosphor imager screens or Kodak BioMax MR film. 
2.7.5 Assaying TFIIS activity 
2.7.5.1 Oligonuceotides used 
 The oligonucleotides used for reconstitution of mono-ECs to test TFIIS activity 
are presented (Table 2.4). 























2.7.5.2 Poly A/T tract assay 
 Mono-ECs were reconstituted in a similar manner as before with 1pmol of TS, 2 
pmol of 32P-end labelled RNA, 3 pmol of RNAPII and 6 pmol NTS (see section 2.7.1) 
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but in this case the oligonucleotides used contained a poly-A/T tract (Table 2.4). 
Following reconstitution, ECs were bound to Streptavidin MagneSphere Paramagnetic 
Particles (Promega) and washed with Transcription Buffer (see section 2.1.5.2) three 
times, prior to aliquoting ECs into 4 tubes and resuspending in 45 µl of Transcription 
Buffer. 5 µl of NTPs (final concentration 500 µM) were added for 1 minute at 25 °C, 
before adding Transcription Buffer, or increasing amounts of recombinant TFIIS (0.1:1, 
0.2:1 or 1:1 molar ratio of TFIIS to RNAPII) for 4 minutes. The reaction was halted by 
the addition of Stop Buffer (see section 2.1.5.5). RNA was isolated and analysed by 
denaturing PAGE (10 % polyacrylamide) in the usual manner (see section 2.7.4). 
2.7.5.3 Backtracking assay 
 Mono-ECs were reconstituted using the G-Stop DNA oligonucleotides (Table 
2.4), purified on Streptavidin beads and aliquoted as before (see section 2.7.5.2) but this 
time transcription (NTPs, no CTP) was allowed to proceed for 5 minutes, prior to 
washing 3 times in Transcription Buffer to remove NTPs. Transcription Buffer or 
increasing amounts of recombinant TFIIS (0.1:1, 0.2:1 or 1:1 molar ratio of TFIIS to 
RNAPII) were added to the ECs and incubated at 25 °C for 5 minutes before the 
reaction was stopped with Stop Buffer. Transcripts were isolated and analysed as before 
(see section 2.7.4). 
2.8 Analysis of transcription in vivo 
2.8.1 Construction of collision and control plasmids 
 The plasmid GAL10-GAL7 used throughout this study was constructed by 
obtaining a GAL10 PCR product using primers targeted 343 bp upstream of the ORF to 
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include all promoter elements (5’AGAGAAAGCTCGAG 
CTTTATTGTTCGGAGCAGTGCGG3’) and 47 bp upstream of the stop codon, to 
ensure no terminator elements were present (5’AGAGAGAGATCGAT 
TCAAGGTTACACAATCTTTCCAGTTCTC3’). This product was cloned between the 
XhoI and ClaI sites of pRS314. A GAL7 PCR product (or GAL7∆TATA PCR product 
for the control) was obtained with primers hybridizing 446 bp upstream of the ORF 
(5’AGAGAGAGGAGCTC ATATCACTCACAACTATTGCGAAGCG3’) and 38bp 
upstream of the GAL7 stop codon (5’AGAGAGAGACTAG 
TTCTTAGTTTTTCAGCAGCTTGTTCCG3’). The fragment was cloned into the SacI 
and SpeI sites in a convergent orientation to the GAL10 gene. A 100 bp G-less cassette 
was PCR amplified from pGAL4CG- (Lue et al., 1989) and cloned into an EcoRI site at 
the 5’ end of the GAL10 ORF to form the promoter proximal G-less cassette (forward 
5’AGAGAGAGGAATTCACTCACCCAATACTCCCTACTC3’; reverse 
5’AGAGAGAGGAATTCGGGAGTGGAATGAGAAATG3’). Finally a 371 bp G-less 
cassette obtained from the 365 bp G-less cassette of pGAL4CG- (forward 
5’AGAGAGAGATCGATCCTCCATACCCTTCCTCC3’; reverse 
5’AGAGAGAGACTAGTGGGAGTGGAATGAGAAATG3’) was cloned into the SpeI 
and ClaI sites between the 3’ ends of the GAL7 (or GAL7∆TATA) and GAL10 ORFs. 
The plasmids pYC10-7Fus and pYC10-7Fus-Δ7 (Prescott and Proudfoot, 2002) used as 
templates for the PCR amplifications above were kindly provided by Nick Proudfoot. 
2.8.2 RNA extraction and Northern blotting 
 Cells were grown in synthetic complete minimal media with raffinose (see 
section 2.5.2) and harvested following addition of 2% glucose or galactose for 75 
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minutes (or after time indicated) at 30 °C and RNA extracted (see section 2.4.1). Equal 
amounts of RNA were treated with 200 U of RNase T1 (Roche) for 1 hour at 37 °C, 
prior to phenol-chloroform extraction (see section 2.4.2). Denaturing-PAGE loading 
buffer (see section 2.1.3.10) was then added to the RNA, which was heated to 65 °C for 
10 minutes and separated by 7% denaturing PAGE (see section 2.1.5.8). RNA was 
transferred to a Hybond-N+ nylon membrane (GE Healthcare) using semi-dry transfer 
blotting at 400 mA for 1 hour and UV-crosslinked. Northern membranes were 
incubated with a random-primed 32P-labelled double-stranded DNA probe 
(corresponding to the long G-less cassette) for 1 hour at 65 °C. This was followed by 4 
washes with WB1 (2 x SSC, 0.05% SDS) for 10 minutes at 25 °C and 2 washes with 
WB2 (0.1 x SSC, 0.1% SDS), each for 15 minutes at 50 °C. Probed membranes were 
exposed to phosphor imager screens or Kodak BioMax MR film. ‘% Distal Cassette 
Transcribed’ was calculated using data from the phosphor imager. The proximal 
cassette signals were equalized for ‘-/+ Convergent Transcription’. The ‘+ Convergent 
Transcription’ distal cassette signal was then calculated as a percentage of the ‘- 
Convergent Transcription’ distal cassette signal (=100%). The mean value and standard 
error were calculated from 2 biological replicates. 
2.8.3 RNA advanced sequencing  
 WT and elc1∆ cells were grown in YPD to mid-log phase prior to total RNA 
extraction (Qiagen RNeasy Kit). RNA was subjected to standard library preparation 
techniques (Illumina), including Ribo-Zero hybrid selection (Epicentre 
Biotechnologies), and Advanced Sequencing on an Illumina GAIIx sequencer. 
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2.9 Chromatin immuno-precipitation 
2.9.1 Chromatin immuno-precipitation 
 Chromatin-immuno-precipitation (ChIP) was performed in WT or elc1Δ strains 
containing GAL10-GAL7 or GAL10-GAL7ΔTATA. For the steady-state ChIP (Figure 
4.3B), cells were crosslinked with 1% formaldehyde for 20 minutes at 25 °C. For the 
kinetic ChIP (Figure 4.7), the 0 minute timepoint was taken after 2 hours in galactose 
and crosslinked prior to the addition of 2% glucose. Timepoints were then taken every 2 
minutes (up to 10 minutes) and crosslinked. Crosslinking was quenched with 200 mM 
glycine prior to resuspension and cell lysis in FA-Lysis buffer (see section 2.1.7.1). The 
chromatin was sonicated to a fragment length of 200-500 base pairs, and then incubated 
with 2.2 µg of 4H8 (anti-CTD antibody), or 2.2 µg mouse IgG (where appropriate) for 2 
hours prior to incubation with Protein G Agarose (Pierce) for 2 hours. Beads were 
washed 3 times for 3 minutes at room temperature in FA-Lysis, once in FA-500 (see 
section 2.1.7.2), once in ChIP-WB (see section 2.1.7.3) and once in TES (see section 
2.1.7.4). Finally, 100 µl ChIP-Elution buffer (see section 2.1.7.5) was added and the 
samples incubated at 65 °C for 10 minutes. 35 µg RNase A (Sigma) was added to the 
eluate for 30 minutes at 37 °C, followed by addition of 20 µg Proteinase K (Roche) for 
2 hours at 42 °C. DNA-protein crosslinks were reversed by incubating at 65 °C for 6 
hours, and the DNA was purified using a PCR Purification Kit (QIAGEN). 
 Quantitative PCR was performed as described (see section 2.3.2) using primers 
targeted to the distal cassette of the GAL10-GAL7 construct (sense 
5’GAGGGGATATGGAAAGGGAA3’; antisense 
5’CCGGTGATTTCTTGTCTGCT3’) as well as control primers directed to the 
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telomeres of chromosome 6 (sense 5’TAACAAGCGGCTGGACTACTTT3’; antisense 
5’GATAACTCTGAACTGTGCATCC3’) and primers targeted to endogenous GAL1 
(sense 5’ACGAGTCTCAAGCTTCTTGC3’; antisense 
5’TATAGACAGCTGCCCAATGC3’). 
 The steady-state ChIP (Figure 4.3B) values were divided by the input and 
telomere values and normalised to the signal for GAL10-GAL7∆TATA (= 1). Values 
obtained for the kinetic ChIP (Figure 4.7) were divided by the input and normalised to 
the 0 minute timepoint (= 100%). Columns on the graphs represent the mean value and 
error bars show standard error, calculated from three biological replicates. 
2.9.2 Chromatin-immuno-precipitation followed by advanced sequencing 
(ChIP-Seq) 
 WT and elc1Δ cells were grown in YPD to mid-log phase and crosslinked as 
indicated earlier; however, cells were resuspended in FA-500 before lysis. Sonicated 
chromatin was incubated for 2 hours with 2.2 µg 4H8 or mouse IgG prior to incubation 
with Protein G Agarose (Pierce) for 1 hour. Beads were washed 3 times for 3 minutes 
with FA-500, twice with FA-Lysis, twice with ChIP-WB and twice with TES. Elution, 
RNase treatment and reverse crosslinking were performed as described for standard 
ChIP (see section 2.9.1). DNA was purified by two rounds of phenol-chloroform 
extraction (see section 2.3.7) followed by ethanol precipitation (see section 2.3.8) 
before being subjected to standard library preparation techniques (Illumina) and 
Advanced Sequencing on an Illumina GAIIx DNA sequencer.  
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2.10 Bioinformatics and computational analyses 
 Bioinformatic analysis was performed in collaboration with Wu Wei and Lars 
Steinmetz (Genome Biology Unit, EMBL). Short read sequences from ChIP-Seq and 
RNA-Seq were aligned to the S288c reference genome (Version 20110326 downloaded 
from the Saccharomyces Genome Database (SGD) (Cherry et al., 1998)) using the 
Novoalign (http://www.novocraft.com) software. Reads at each position along the 
genome were extracted. In ChIP-Seq data analysis, ChIP signals (Log2 values) were 
divided by the relative IgG control for each genomic position excluding the ones with 
<5 reads coverage. Quantile normalisation between samples was then performed. 
Normalised ChIP-Seq values for the regions flanking the middle positions of intergenic 
regions (+/- 500bp) between convergent or divergent gene pairs were extracted and the 
median values of the signal in each position in these gene pairs were calculated and 
plotted. 
 RNA-Seq coverage at each position along the genome was divided by the total 
number of reads mapped in each sample. Regions flanking the end positions of every 
gene (+/- 500bp) were taken, and normalised RNA-Seq signals extracted for every gene. 
The mean values of RNA-Seq signals at each position in all genes were calculated and 
plotted.  
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Chapter 3. A study of RNA Polymerase II convergent 
transcription in vitro 
3.1 Introduction 
 The underlying complexity of the transcriptional landscape has been highlighted 
in recent studies which show that non-coding transcription (and especially concurrent 
antisense transcription (Katayama et al., 2005, Vallon-Christersson et al., 2007)) is 
highly prevalent at genes (Carninci, 2010, Jacquier, 2009, Berretta and Morillon, 2009). 
Additionally, genes can be organised into sense-antisense pairs, sometimes without 
terminators between them (Xu et al., 2011). This raises important questions about 
sense-antisense transcription and the ability of RNAPII molecules to transcribe the 
same piece of DNA at the same time, as they indeed do. Convergent transcription must 
result in RNAPII interactions/collision, even if this is a rare occurrence. 
 It is the aim of this chapter to present results concerning the nature of 
interactions between convergently transcribing RNAPII molecules. There are several 
unanswered and important questions concerning convergent transcription, answers to 
which are required to understand this process in vivo: 
1. Can RNAPII molecules transcribe past one another? 
2. If not, what is the fate of the RNAPII molecules upon collision? 
3. Are there auxiliary factors that control/facilitate transcriptional bypass? 
 In order to address these questions, a convergent transcription template had to be 
developed that was amenable to biochemical manipulation and capable of providing 
robust mechanistic data. Interactions between tandemly transcribing RNAPII molecules 
have been extensively studied using an in vitro biochemical scaffold system (Saeki and 
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Svejstrup, 2009) (see section 1.6), modified from a basic assay originating in the 
Kashlev laboratory (Kireeva et al., 2000). This provided the template for the 
development of a convergent transcription template and was selected due to its many 
advantages over initiation factor-based or tailed-template systems. Firstly, elongation 
can be reconstituted and studied directly without the need for additional factors. 
Secondly, reconstituted ECs have an identical footprint and transcription bubble size as 
that of promoter-driven ECs (Saeki and Svejstrup, 2009). Thirdly, extended DNA-RNA 
hybrids do not form (as in the tailed-template system). Fourthly, all aspects of the 
system can be controlled, and finally, purified proteins can be added (Sigurdsson et al., 
2010). Furthermore, initiation in promoter-based systems is remarkably inefficient, 
whilst the scaffold system used here allows pre-positioning and purification of 
appropriate templates before starting transcription. 
 The first part of this chapter will be concerned with characterising the 
experimental system to reconstitute convergent transcription in vitro. Later sections will 
detail the use of this system to deduce the outcome of RNAPII interactions, focussing 
specifically on the nature of collision and its effect on EC stability. Finally, experiments 
addressing addition of TFIIS and transcription-competent extract will be presented, with 
a focus on the implications of this for our understanding of RNAPII interactions and 
gene traffic in general. 
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3.2 Elongation can be reconstituted on an oligonucleotide-
based scaffold system with purified RNAPII 
 Eukaryotic RNAPII is highly conserved even between organisms as diverse as 
humans and yeast (see section 1.1.1). Additionally, the ease of purifying large amounts 
of RNAPII from Saccharomyces cerevisiae makes it an ideal source of protein for 
reconstitution assays.  
RNAPII was purified to homogeneity from yeast extract using a procedure 
developed in the Kornberg lab (Cramer et al., 2001) (see section 2.6.4) (Figure 3.1A): 
heparin purification, ammonium sulphate precipitation, 8WG16 immuno-precipitation 
and finally MonoQ anion exchange chromatography. Significant purification occurred 
as a result of immuno-precipitation using the CTD-specific antibody 8WG16, followed 
by stringent high salt washes. A key advantage of the 8WG16 antibody column is its 
high specificity and the ease with which RNAPII can be eluted by the addition of buffer 
containing 50% glycerol. SDS-PAGE analysis of eluted fractions shows the almost pure 
12-subunit RNAPII and a few co-eluting protein contaminants (Figure 3.1B, * and **). 
The peak fractions from the 8WG16 column were then pooled and subjected to anion 
exchange chromatography on a MonoQ column and eluted over a KCl gradient. The 
peak fractions were analysed by SDS-PAGE (Figure 3.1C). This step resulted in the 
recovery of highly concentrated and pure RNAPII, free from the starting contaminants 
(compare to Figure 3.1B).  
To reconstitute ECs on the oligonucleotide scaffold, it is imperative that highly 
purified reagents are used. This aids in reproducibility ensuring that reconstituted ECs 
are more homogeneous. Therefore, in addition to pure RNAPII, all oligonucleotides 
were PAGE-purified before use in the assay (see section 2.3.13 and 2.4.5). This is  




Figure 3.1 Purification of RNAPII from S. cerevisiae.  
A. Schematic showing the purification schedule employed. B. Coomassie-stained SDS-
polyacrylamide gel showing the first five fractions eluted from the 8WG16 column. * and ** 
are co-eluting contaminants. RNAPII subunits indicated, right. C. Coomassie-stained SDS-gel 
of the MonoQ peak fractions. 
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especially relevant here, as the oligonucleotides are 150 nt long and synthesis of such 
long DNA is relatively inefficient. Next, it was necessary to determine if the highly 
purified RNAPII was functionally active and could be used to successfully reconstitute 
ECs on the scaffold system. Therefore, ECs were reconstituted from oligonucleotides  
and the purified RNAPII in a stepwise manner (Figure 3.2A) (see section 2.7.1). Native 
agarose electrophoresis was used to assess EC formation, with the presence of a discrete 
low-mobility band indicating correct formation (Saeki and Svejstrup, 2009). The 
purified RNAPII did indeed form ECs efficiently giving rise to a discrete band (Mono-
EC, Figure 3.2B). Next, it was important to determine if the reconstituted EC was active 
and able to transcribe the DNA template. NTPs were added to initiate transcription for 5 
minutes, the RNA was isolated and analysed by denaturing PAGE. The data show that 
the RNAPII isolated and ECs formed were indeed highly active and able to extend the 9 
nt RNA to the full-length product, with very few ECs arresting on the template or 
producing truncated RNAs (Figure 3.2C), which would be indicative of low RNAPII 
processivity or problems during reconstitution.  
A system for purification of RNAPII and reconstitution of ECs has thus been 
implemented. The purity of transcription and the homogeneous nature of ECs, as shown 
by native agarose electrophoresis, provide a platform for more detailed elongation 
assays. Due to the efficiency of mono-EC transcription, any inhibition of full length 
RNA production should be clearly evident in subsequent convergent transcription 
experiments. This assay was, therefore, suitable as the basis for the following 
experiments in which a second EC was reconstituted on the opposite strand of DNA. 




Figure 3.2 Reconstitution of elongation in vitro using purified RNAPII.  
A. Schematic indicating the method for EC reconstitution, grey oblong is RNAPII and black 
sphere 32P label. B. Autoradiograph of native agarose gel showing a reconstituted EC, which 
forms a discrete band. C. Denaturing PAGE of RNA isolated from EC analysed in B. FL RNA 
is full-length RNA. 
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3.3 Di-elongation complexes can be reconstituted in vitro 
 In order to study the phenomenon of convergent transcription, modifications 
were made to the scaffold system. Conditions were found in which two RNAPII 
molecules could be loaded onto the same piece of double-stranded DNA, orientated to 
transcribe towards each other. Scaffolds of this nature were obtained by forming 
separate DNA-RNA-RNAPII intermediates and finding conditions in which they would 
hybridise to form one transcription template (Figure 3.3A, Di-EC). 
 During the reconstitution reaction, two pools of partially formed ECs (DNA-
RNA-RNAPII) were assembled. One of these ECs was radioactively labelled so that its 
transcription could be assessed (designated 32P-RNA1-EC). The DNA oligonucleotide 
used as the NTS for this radioactively labelled EC was incubated with a complimentary 
RNA primer and RNAPII (referred to as RNA2-EC), and to bias di-EC formation 
increasing amounts of this complex was mixed with fixed amounts of the 
complementary TS-RNA-RNAPII complex, carrying the radioactively end-labelled 
RNA (32P-RNA1-EC) (Figure 3.3A, Di-EC). Upon mixing, the two intermediate ECs 
should hybridise and form di-ECs (see Figure 3.3A, Di-EC schematic). Reconstituted 
mono-ECs and putative di-ECs were incubated with NTPs and transcription allowed to 
proceed for 5 minutes. The RNA was isolated and resolved by denaturing PAGE.  
 The mono-EC transcribed to the end of the DNA template, producing full-length 
RNA, as expected (Figure 3.3B, lane 1). Addition of increasing concentrations of 
RNA2-EC resulted in a decrease in the amount of full-length RNA produced from 32P-
RNA1-EC (Figure 3.3B lanes 2-4), along with the formation of novel truncated RNAs, 
of approximately half the size of full-length RNA. This finding was indicative of an  
 




Figure 3.3 Reconstitution of di-ECs in vitro.  
A. Schematic showing a mono-EC (upper) and the method for reconstituting di-ECs (lower) 
using increasing amounts of RNA2-EC. B. Denaturing PAGE of RNA isolated from mono-ECs 
(M) and complexes formed by titrating 2, 4, or 6 times molar excess of RNA2-EC. Full-length 
RNA (FL) is indicated along with ‘Collision’ products. 
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impediment to transcription. Interestingly, there was a correlation between the 
production of truncated RNA and the disappearance of the full-length product and this 
occurred in an RNA2-EC concentration-dependent manner. A 6x excess of RNA2-EC 
over 32P-RNA1-EC produced the greatest amount of truncated, and smallest amount of 
full-length RNA, presumably arising as a result of a transcriptional block imposed by 
the presence of the second RNAPII molecule (Figure 3.3B, lane 4). In further support of 
this assertion, the length of truncated products is approximately consistent with 
expectations after considering the predicted footprint of the second EC on the DNA 
(Gnatt et al., 2001). If ECs do indeed impede each others progression, then transcription 
from the opposite direction should also produce RNA of a similar size. To test this, di-
ECs were again reconstituted, but this time with RNA2-EC containing the end-labelled 
RNA and incubated with 6x excess of RNA1-EC (Figure 3.4A). The transcription 
products isolated show that transcription in the opposite direction also produces 
truncated RNA products, of a similar size to those seen before and reduced levels of 
full-length RNA (compare Figure 3.4B lane 2 to Figure 3.3B, lane 4). This suggests that 
the truncated RNA is indeed produced as a result of collision between the two ECs 
rather than as the result of an artefact.  
 In conclusion, the data shown so far indicate that the presence of another 
RNAPII molecule on the DNA template is inhibitory to elongation, as RNAPII 
processivity is reduced. This finding has important implications for transcription on 
highly transcribed DNA. However, the presence of some full-length RNA product 
indicates that there might be a fraction of RNAPIIs with the ability to bypass one 
another, and the next section, therefore, focuses on the isolation of purified di-ECs 
(lacking contamination by mono-ECs) for the purpose of studying this.    






Figure 3.4 Analysis of transcripts from the other EC.  
A. Diagram indicating EC position on the DNA template and location of labelled RNA. B. 
Transcription products isolated from ECs. Full-length RNA and Collision bands indicated, in 
addition to RNA produced by mis-primed ECs *. 
Chapter 3 Results 
 
 109 
3.4  Purified di-ECs show that convergently transcribing 
RNAPII molecules cannot transcribe past each other 
 Having found conditions for the formation of di-ECs, it was necessary to 
determine if the full-length RNA observed in the previous experiment was a result of 
contaminating mono-ECs or a fraction of RNAPII molecules bypassing one another. 
Due to the nature of the reconstitution reaction and its inherent inefficiency, a range of 
different products will undoubtedly be present in the EC mixture and so a method was 
devised to isolate di-ECs from other observable formation intermediates, which may be 
giving rise to full-length RNA in the di-EC reactions (Figure 3.5A). The approach used 
employed the formation of di-ECs with two differently epitope-tagged RNAPII 
molecules, enabling isolation of di-ECs by two-step affinity-purification (Figure 3.5B). 
 RNAPII was purified from two yeast strains: one with sequence encoding a C-
terminal FLAG-tag inserted into the RPB3 gene and the other with a sequence encoding 
a C-terminal HA-tag inserted into the RPB1 gene. The presence of the FLAG-tag on 
Rpb3 resulted in a visible mobility shift during SDS-PAGE (Figure 3.6A). Di-ECs were 
reconstituted with the two different RNAPII forms (using the same method as before) 
and then both mono- and di-ECs were incubated with Anti-FLAG M2 Agarose to 
isolate templates containing the labelled EC. Bound complexes were washed stringently 
with a high-salt buffer followed by several washes in 20 mM Tris pH 7.5 and elution 
with FLAG-peptide. Di-ECs were then subjected to a second round of purification using 
Anti-HA Affinity Matrix, to isolate transcription templates that also contained the non-
labelled EC, followed by washes and resuspension in Transcription Buffer (see section 
2.7.2). This method allowed the isolation of true di-ECs. 









Figure 3.5 Representation of reaction products and di-EC purification schedule.  
A. Diagram showing expected observable reaction products. B. Di-EC with positioned epitope-
tagged RNAPII molecules (upper) and a purification schedule for isolating di-ECs. 
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The exact starting position of RNAPII on the DNA template is known; therefore, 
the expected length of RNA products can be calculated, with both mono- and di-ECs 
having the potential to produce 119 nt RNA when incubated with all NTPs (AUCG) 
(Figure 3.6B). NTPs were added and isolated RNA products resolved by denaturing 
PAGE (Figure 3.6C). As expected, the mono-ECs transcribed the full length of the 
template and produced a run-off product of 119 nt (lane 1). However, the di-ECs did not 
(compare lanes 1 and 2), instead creating a range of prominent truncated RNAs 
(indicated, right). The absence of full-length RNA indicates that convergent 
transcription leads to RNAPII head-to-head collisions, which impede further 
transcription. These data indicate that RNAPII molecules are unable to bypass one 
another, but instead impede one another’s progress during elongation. 
By adding all NTPs in this experiment both RNAPII molecules had the potential 
to transcribe the length of the template. It is likely that the smaller truncated RNA 
products (26-40 nt) are a result of collision distributed across the DNA template, with 
both polymerases moving forward leading to collision at random sites. Interestingly, 
however, these truncated RNAs appear to correspond to sites of RNAPII pausing in the 
mono-EC reaction as well (Figure 3.6C, compare lanes 1 and 2). Presumably, these 
transcripts are also more abundant in the di-EC reactions because the longer residence 
time at pause sites increases the likelihood of an encounter with the opposing 
polymerase, preventing continued transcription.  
 The absence of RNAPII transcriptional bypass was slightly surprising, 
considering the observations reported by others in the bacteriophage system (Ma and 
McAllister, 2009). It is also surprising when taking into account all the antisense 
transcription that has been reported in vivo (see section 1.5.2). However, in this basic  






Figure 3.6 Formation and purification of di-ECs with FLAG- and HA-RNAPII.  
A. Coomassie-stained SDS-polyacrylamide gel of FLAG-RNAPII and HA-RNAPII. B. 
Schematic representation of mono-ECs (upper) and di-ECs (lower) showing starting positions 
and predicted transcript lengths. C. Denaturing PAGE of RNA products isolated from mono- 
(M) and di-ECs (D) in the presence of all NTPs (AUCG). Observed transcript length, right. 
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biochemical system, RNAPII is not associated with any of the myriad elongation factors 
that facilitate transcription in vivo (see section 1.3.2.1). Conceivably, some of these 
could be necessary also to facilitate transcriptional bypass. This theory was tested with 
experiments presented later in this chapter. 
3.5 Spatial invasion does not occur as a result of head-to-head 
RNAPII collision  
 The truncated RNAs produced in the presence of all NTPs had to be 
characterised further to fully elucidate their origin and identity. This was achieved by 
reconstituting ECs on DNA templates containing a C-less TS downstream of RNA1-EC 
but a C-rich TS for RNA2-EC. C-residues were positioned such that in the presence of 
NTPs (no GTP) the EC carrying the labelled RNA could in theory transcribe to the 
other side of RNA2-EC in the absence of added GTP, to produce a 117 nt RNA product, 
whereas the unlabelled EC in di-ECs would stop after transcribing just 1 nt (Figure 
3.7A). The importance of performing this kind of experiment is two-fold; firstly, the 
point of RNAPII collision can be precisely defined to test which truncated transcripts 
are a result of randomly distributed collision and secondly, due to prior knowledge of 
the DNA region covered by RNAPII in an elongation complex (Gnatt et al., 2001), the 
ability of RNAPII molecules to invade one another’s space on DNA can be studied. 
This was particularly pertinent, given that head-to-tail collision has been shown to 
involve dramatic temporary invasion (Saeki and Svejstrup, 2009). 
 The reconstituted ECs were purified as before, incubated with NTPs (no GTP) 
and RNA isolated. As expected, the mono-EC transcribed up to the C-stop and 
produced the full-length 117 nt transcript (Figure 3.7B, lane 1). Also as expected, the  




Figure 3.7 Transcription into a stalled RNAPII EC.  
A. Diagram showing reconstituted mono- and di-ECs with theoretical RNA products indicated. 
B. Denaturing PAGE of RNA products isolated following transcription (ATP, UTP and CTP). 
Transcripts indicated, right. Note the disappearance of transcripts between 26 and 40 nt length 
(inclusive). 
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di-ECs did not reach the C-stop but instead produced the prominent 51-55 nt RNA 
products seen previously (Figure 3.7B, lane 2). Interestingly, the shorter transcripts 
produced in the presence of all NTPs (26-40 nts) (Figure 3.6C, lane 2) were not 
observed, confirming that these were indeed the result of randomly distributed collision, 
mainly localising to pause sites.  
 The nature of the scaffold system and the use of high purified reagents allows 
the exact positioning of RNAPII through the use of an RNA primer, providing 
knowledge of the precise starting- and end-point of transcription (Figure 3.8A). The 
footprint of RNAPII on DNA and the position of the DNA-RNA hybrid are also known 
from structural studies (Gnatt et al., 2001, Wang et al., 2006, Kettenberger et al., 2004). 
Therefore, if the EC containing the labelled RNA is moved forward 55 bp 
(corresponding to the longest RNA produced) then the degree of overlap between 
RNAPII molecules (and thus invasion) can be determined. The outcome of this analysis 
is that convergently transcribing RNAPII molecules appear to be virtually unable to 
invade one another – transcription stops as soon as the leading edges of the polymerases 
touch (Figure 3.8B). Interestingly, this is in sharp contrast to tandem transcription 
collisions, where temporal, but extensive, structural intermingling of polymerases was 
observed (Saeki and Svejstrup, 2009). This helps explain why RNAPII molecules in this 
highly purified system are unable to bypass one another, with the presence of bulky 
protein domains likely inhibiting displacement of the non-transcribed strands. 
Furthermore, this might explain the finding that bacteriophage RNAP molecules can 
bypass one another. In this simple system, there is a lack of protein density around the 
polymerase core, which could allow the enzymes to transcribe the same template (Ma 
and McAllister, 2009, Durniak et al., 2008, Cramer et al., 2001). This suggests that the  












Figure 3.8 Diagram representing ECs before and after collision.  
A. Representation of di-ECs before transcription showing the direction of RNAPII movement 
(arrows) and indicating the position of C-stops on the DNA template. RNAPII (oblong) 
footprint derived from the crystal structure (Gnatt et al., 2001). B. ECs shown after transcription 
with transcript lengths observed (Fig. 3.7B) indicated. 
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mechanism of convergent transcription is very different between eukaryote and 
bacteriophage polymerases. 
3.6 Increased transcription time is insufficient to allow RNAPII 
molecules to bypass each other 
 In all of the experiments presented above, transcription reactions were allowed 
to occur for a relatively short time period (5 minutes). It is an interesting possibility that 
transcription time could have an affect on the ability of polymerases to bypass one 
another and indeed, as previous studies have shown, some transcription past a DNA 
damage lesion or pause site can occur with increased transcription time (Walmacq et al., 
2012, Izban and Luse, 1991, Dimitri et al., 2008). Therefore, increased transcription 
times were tested to determine if they would have an effect on transcriptional bypass. 
 Di-ECs were reconstituted, purified by dual immuno-purification (see section 
3.4) and then incubated with NTPs for increasing periods of time. Transcription 
products isolated from these di-ECs (Figure 3.9) displayed a similar size distribution, 
even after increased transcription time (compare lanes 1 and 4). Neither the intensity of 
the truncated RNA bands nor the level of 119 nt RNA changed considerably with 
increased transcription time, ruling out the possibility that significant transcriptional 
bypass occurs with time.  
 In conclusion, the data presented so far indicates either that di-ECs collide, 
impede each others progress, and remain fairly stable upon collision, or that following 
collision, one of the polymerases falls off the DNA, and the other RNAPII enters into 
an arrested or backtracked state, requiring re-activation by external factors. 





Figure 3.9 Timecourse of di-EC transcription.  
Denaturing PAGE of RNA products obtained from purified di-ECs incubated with NTPs for 5, 
10, 30, or 60 minutes prior to terminating transcription. RNA length indicated, right. 
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3.7 Elongation complexes are stable following collision 
 The observation that RNAPII molecules are unable to transcribe past each other 
raises questions about the fate of collided ECs. It is possible, for example, that the force 
of impact between the two molecules causes stress to the structure of the EC and 
possibly leads to RNAPII dissociation from DNA. On the other hand, ECs are 
inherently extremely stable (Kireeva et al., 2000), and collisions between tandemly 
transcribing di-ECs, where transient but significant structural changes occur, lead to 
little or no EC dissociation (Saeki and Svejstrup, 2009).  
 To assess EC stability upon collision, native agarose gel electrophoresis of 
reconstituted mono- and di-ECs was performed either before or after transcription 
(Figure 3.10A). Mono-ECs (lane 1 and 3) migrated on the agarose gel as seen 
previously (Figure 3.2B), whereas di-ECs migrated more slowly, owing to their 
increased molecular weight (lanes 2 and 4). A similarly reduced mobility was seen 
previously for tandemly arranged di-ECs (Saeki and Svejstrup, 2009). Interestingly, 
after transcription, little, or no, di-EC dissociation was observed (compare the intensity 
of di-EC in lane 2 and lane 4) and nascent RNA could be isolated directly from the 
bands corresponding to mono- and di-ECs on the native agarose gel and resolved by 
denaturing PAGE (Figure 3.10B). The isolated RNA was of an identical size to that 
seen previously for mono- and di-ECs (Figure 3.7) and thus confirms that the bands 
observed on the native agarose gel are indeed mono- and di-ECs. 
 A similar analysis was performed, adding all NTPs to initiate transcription from 
both RNAPII molecules. Again, the vast majority of Di-ECs remained intact (Figure 
3.11A) and isolated nascent RNA showed the profile observed for immuno-purified di-
ECs (compare Figure 3.11B, lanes 1 and 2 to Figure 3.6C lanes 1 and 2). These data  




Figure 3.10 Analysis of di-ECs following transcriptional collision.  
A. Native agarose gel of unpurified mono- (M) and di-ECs (D) before (lanes 1 and 2) or after 
(lanes 3 and 4) transcription. Unincorporated RNA primer is indicated (Free RNA). B. 
Denaturing PAGE of RNA isolated from the mono- (M) or di-EC (D) positions on a native gel. 
RNA sizes indicated, right. 







Figure 3.11 Stability of ECs when both polymerases are transcribing. 
A.  Sybr Gold-stained native agarose gel of mono-(M) and di-ECs (D) after transcription. B. 
Denaturing PAGE analysis of nascent transcripts isolated from ‘Mono’ and ‘Di’ positions in A. 
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show that the forces generated during collision are insufficient to push RNAPII off the 
DNA template, supporting previous data concerning EC stability (Kireeva et al., 2000, 
Saeki and Svejstrup, 2009). Importantly, this rules out EC dissociation as a major 
method for RNAPII bypass and suggests that alternative mechanisms and factors may 
exist in vivo to support RNAPII bypass. The following sections will focus on testing 
this hypothesis. 
3.8 RNAPII cannot overcome transcriptional collision through 
TFIIS activity 
The elongation factor TFIIS is able to stimulate RNAPII intrinsic RNA cleavage 
activity and can be purified from recombinant sources (Sigurdsson et al., 2010). TFIIS 
has previously been shown to stimulate RNAPII transcription through various 
elongation blocks (Fish and Kane, 2002). Therefore, TFIIS could play a role in 
facilitating transcriptional bypass between di-ECs. It is also likely that upon initial 
transcriptional collision, RNAPII backtracks, as seen for tandem di-ECs (Saeki and 
Svejstrup, 2009), resulting in arrest. As arrested/backtracked RNAPII requires TFIIS to 
resume transcription, arrest could provide an explanation for the lack of transcriptional 
bypass observed even during increased transcription time (see section 3.6). 
A His-tagged form of yeast TFIIS was expressed in E.coli, purified via nickel-
affinity chromatography (Figure 3.12A) and tested for activity using two assays. The 
first assay measured transcription through a pause-inducing poly A/T tract (Saeki and 
Svejstrup, 2009, Sigurdsson et al., 2010) (Figure 3.12B, schematic). Previously, it has 
been shown that RNAPII is able to transcribe through a pause site and produce full-
length RNA upon TFIIS addition (Sigurdsson et al., 2010). To test the activity of  




Figure 3.12 Purification of TFIIS and transcription through a pause-site.  
A. Coomassie-stained SDS-polyacrylamide gel of Ni-NTA peak fraction of recombinant TFIIS. 
B. Upper, diagram representing mono-EC reconstituted with poly-A/T tract represented (A9). 
Lower, schematic showing experimental procedure. C. Denaturing PAGE of RNA products 
isolated from ECs without (-) TFIIS or with increasing amounts of protein (0.1:1 molar ratio of 
TFIIS to RNAPII (lane 2), 0.2:1 (lane 3) and 1:1 (lane 4)). Presence of the poly-A/T pause site 
indicated, right. 
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purified TFIIS, mono-ECs carrying a 3’ biotin tag on the TS (Table 2.4) were 
reconstituted and bound to Streptavidin beads. The ECs were then incubated with NTPs 
for 1 minute followed by incubation with buffer or increasing amounts of TFIIS for 4 
minutes. RNA isolated from these ECs clearly shows that the recombinant TFIIS could 
facilitate transcription past the pause site and that this occurred in a concentration-
dependent manner (Figure 3.12C compare lanes 1 to 2, 3 and 4). When RNAPII and 
TFIIS were at an equimolar ratio very few polymerases remained paused at the A/T 
tract, with the majority transcribing the entire template (lane 4). These data show that 
the recombinant TFIIS could stimulate cleavage of nascent RNA by RNAPII, allowing 
repeated attempts at transcribing across the pause site.  
As a second assay, ECs were formed on a transcription template with a G-less 
region immediately downstream of the EC, ending with two guanines in a row (a G-
stop) (Table 2.4), and bound to Streptavidin beads to measure the stimulation of nascent 
transcript cleavage by TFIIS. In this instance NTPs (no CTP) were added to the 
elongation complexes and incubated for 5 minutes to allow transcription to the G-stop, 
prior to washing away NTPs and the addition of buffer (Figure 3.13B, lane 1), or 
increasing amounts of TFIIS (lanes 2-4) for 5 minutes. Full-length RNA can be 
observed for the –TFIIS control. However, its level is dramatically decreased upon the 
addition of increasing amounts of TFIIS. Indeed, at a 1:1 molar ratio (lane 4), ECs that 
have not yet begun transcribing are caught and instead, begin to cleave their RNA 
primer to less than 9 nt in length. These data support the conclusion that RNAPII is 
indeed backtracking and cleaving its RNA in the presence of recombinant TFIIS. 
 
 





Figure 3.13 Assay of TFIIS ability to stimulate transcript cleavage activity.  
A. Schematic of EC showing the presence of G-stop and experimental procedure. B. Denaturing 
PAGE of RNA isolated from ECs without (-) or in the presence of, increasing amounts of TFIIS 
(0.1:1 molar ratio of TFIIS to RNAPII (lane 2), 0.2:1 (lane 3) and 1:1 (lane 4)). 
 
Chapter 3 Results 
 
 126 
These experiments showed that the recombinant TFIIS was highly active, and it 
was therefore now added to di-ECs to determine its ability to stimulate polymerase-
polymerase bypass. Di-ECs were reconstituted as before and TFIIS added. Di-ECs were 
incubated with NTPs and TFIIS for 5 to 60 minutes and RNA analysed by denaturing 
PAGE. In contrast to the results obtained for the timecourse in the absence of TFIIS 
(see section 3.6), di-ECs incubated with TFIIS were able to produce a small amount of 
full-length RNA at the 5 minute timepoint (Figure 3.14, lane 1) and this increased in a 
time-dependent manner (lanes 2-4).  
Previous work with tandem, collided di-ECs has shown that after RNAPII 
collision, polymerases oscillate back and forth between a backtracked and forward 
translocated state in the presence of NTPs and TFIIS (Saeki and Svejstrup, 2009). At 
first glance, it seems likely that this is also the case during head-to-head collision and 
that it helps facilitate transcriptional bypass, but for a number of reasons it is difficult to 
draw firm conclusions from this experiment. Firstly, ‘bypass’ is very low, even upon 
incubation with TFIIS and NTPs for 1 hour; secondly ‘bypass’ correlates with a 
significant increase in the level of truncated RNA 9mer (<9 nt length). This opens up 
the possibility that unlabelled ECs that did not start transcribing prior to TFIIS action 
are being destabilised by cleaving their short RNA primer, and thus dissociating from 
the DNA. This would then allow the labelled EC to transcribe the template unimpeded. 
Following these inconclusive data, it was therefore decided to test transcription-
competent extract for a more pronounced activity. 
 




Figure 3.14 A timecourse of transcription by di-ECs in the presence of TFIIS.  
Denaturing PAGE of RNA products from a timecourse of NTP and TFIIS incubation. RNA 
lengths are indicated (right). 
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3.9 Addition of transcription-competent extract to di-ECs 
 Following the somewhat ambiguous evidence for a role of TFIIS in assisting 
RNAPII bypass, transcription-competent extract from dst1∆ cells was tested for a 
bypass activity. dst1∆ cells lack the gene encoding TFIIS and should therefore allow 
detection of any TFIIS-independent bypass activity. Mono- and di-ECs were 
reconstituted and purified using the dual immuno-purification technique (Figure 3.15A), 
and incubated with extract for 30 minutes before the RNA products were analysed 
(Figure 3.15B). Pre-incubation with extract had a dramatic effect on mono-EC 
transcription efficiency, with higher levels of full-length RNA being produced (compare 
lanes 1 and 2). This effect was maximal upon the addition of 50 µg of extract, 
suggesting that saturation had been reached (compare lanes 2 and 3). The stimulation of 
transcription through the addition of extract is interesting and likely arises as a result of 
unknown elongation factors acting on ECs to increase RNAPII processivity (see section 
1.3.2.1). Yeast lacks basic elongation factors such as Elongin and ELL, and TFIIF does 
not stimulate transcript elongation by yeast RNAPII. It would therefore be of future 
interest to isolate the responsible activity. Interestingly, pre-incubation of di-ECs with 
extract also stimulated the production of 119 nt RNA (compare lanes 4-6), suggesting 
transcriptional bypass. Unfortunately, there was also a concomitant increase in 
‘collision’ RNA products, which might indicate alternative explanations. In these 
experiments it, thus, cannot be ruled out that the addition of extract stimulates a very 
minor fraction of contaminating mono-ECs, usually not observable in the absence of 
stimulation, or that the extract contains a factor that can dissociate elongation 
complexes, so that the labelled EC in some cases can progress unhindered. The  






Figure 3.15 ECs pre-incubated with extract. 
A. Schematic detailing experimental procedure. B. Mono- (lanes 1-3) and di-ECs (lanes 4-6) 
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presence of increased amounts of truncated RNA upon the addition of extract (compare 
lane 4 to 5 and 6) supports this interpretation. In an ideal situation, increased full-length 
RNA would be accompanied by a concomitant loss of truncated RNA if transcriptional 
bypass were occurring. 
 A different approach was also employed to assay activity present in the extract. 
To prevent bias towards an EC removal factor, ECs were reconstituted and dst1∆ 
extract added simultaneously with NTPs, followed by 5 minutes incubation at room 
temperature (Figure 3.16A), prior to native agarose electrophoresis and isolation of di-
ECs. Interestingly, RNA from these isolated di-ECs (Figure 3.16B) showed no 
stimulation of bypass in the presence of extract (compare lane 4 with 5 and 6). Due to 
the experimental setup, only intact di-ECs were isolated and the levels of contaminating 
mono-ECs or dissociated complexes were much lower than when the dual-IP method 
was used.  
 In conclusion, although tentative evidence for the existence of an RNAPII 
bypass factor was uncovered using the in vitro system, the difficulty of producing and 
purifying a large amount of di-ECs means that it is not an amenable substrate for use in 
subsequent biochemical fractionation experiments. 






Figure 3.16 ECs incubated with extract and NTPs simultaneously. 
A. Schematic detailing experimental procedure. B.  Transcription analysis arranged as in Figure 
3.15B. 
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3.10  Conclusions 
 The data presented in this chapter concern the fundamental nature of convergent 
transcription in vitro, providing a biochemical insight into the consequence of collision. 
Numerous experiments were performed using a robust convergent transcription system 
reconstituted from highly purified reagents. The presence of a convergently transcribing 
EC forms a potent block to transcript elongation, resulting in RNAPII arrest as soon as 
the front edge of the proteins touch. These data indicate that collided RNAPII molecules 
are highly stable; remaining bound to the DNA template and associated with their 
nascent RNA product.  
 Due to the numerous RNAPII-associated factors present in vivo, more complex 
experiments were performed in the presence of TFIIS and cell-free yeast extract. These 
results show that arrested elongation complexes can be restarted by the addition of 
recombinant TFIIS, but this seems unable to stimulate significant RNAPII bypass. 
Likewise, while the addition of transcription-competent extract provides tentative 
evidence for the presence of an RNAPII bypass factor it first and foremost results in 
increased transcription efficiency, possibly resulting from the action of Spt4/5 or other 
unknown factors present in the extract (see section 1.3.2.1). 
 Taken together, the in vitro data present convergent transcription as a highly 
problematic event, which is further exacerbated by the extreme stability of ECs on DNA. 
In vivo, such an event would, at the very least, be expected to result in transcription 
arrest, preventing further expression of a particular gene and requiring alternative 
mechanisms to resolve it. It is possible that the collision bypass/resolution mechanism 
involves proteins inactive in, or co-factors absent from, the extract experiments. 
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Interestingly, however, it is also an obvious possibility that collision elicits a response 
similar to that triggered by RNAPII stalled at DNA damage, namely ubiquitylation and 
proteasome-mediated polymerase degradation (see section 1.3.3.2). In order to test these 
possibilities, it was necessary to move to in vivo systems, allowing the study of 
convergent transcription in its physiological setting. 
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Chapter 4. RNAPII collision and its resolution in vivo 
4.1 Introduction 
 The finding that RNAPII convergent transcription leads to head-to-head 
collision and polymerase arrest has profound consequences for transcription in vivo. 
Such arrest of transcription in cells is undesirable and can be detrimental, as stalled 
RNAPII can interfere with other DNA metabolic events, such as replication (Pomerantz 
and O'Donnell, 2010). Moreover, the presence of arrested RNAPII on a gene is, of 
course, a potent block to further transcription of that gene by other polymerases, and 
consequently pathways have evolved to efficiently remove or re-start stalled RNAPII 
(Svejstrup, 2007a, Somesh et al., 2005, Woudstra et al., 2002, Harreman et al., 2009, 
Sigurdsson et al., 2010) (see section 1.3.3.2). Thus, it can be expected that a pathway(s) 
exists that resolves collisions following convergent transcription. Additionally, it is 
necessary to study the nature of collisions in vivo because the ECs in the basic, 
reconstituted system do not fully mimic the multi-factored, dynamic ECs found in cells.  
 The aim of this chapter is, therefore, to perform an analysis of convergent 
transcription in vivo using the genetically malleable organism, S. cerevisiae. The 
experiments performed aim to answer the following questions: 
1. Can transcriptional collision be observed in vivo. If so, does transcriptional 
bypass occur? 
2. If not, what is the fate of RNAPII upon collision? 
3. How is collision resolved? 
The overriding goal is to determine the relevance of the biochemical data (see Chapter 
3) in a physiological setting. The data presented here are derived from two different 
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experimental sources: firstly, a convergent gene construct with which in vivo 
biochemistry as well as chromatin immuno-precipitation (ChIP) experiments were 
performed, and, secondly, endogenous gene pairs for genome-wide ChIP studies. The 
results obtained outline the consequence of head-to-head collision in vivo and support a 
role for the RNAPII ubiquitylation system in its resolution. 
4.2 A convergent transcription construct to study RNAPII 
collision in vivo 
 The occurrence of RNAPII collision in vivo is likely to be stochastically 
distributed across large areas of DNA making its detection at any specific site difficult. 
It was therefore surmised that the likelihood of observing it at any specific site is 
minimal. In order to induce collisions at a specific, observable DNA locus, a plasmid 
was constructed using the well characterised, inducible, and highly transcribed GAL 
genes. The construct was based on a plasmid previously used in the Proudfoot 
laboratory (Prescott and Proudfoot, 2002) but modified so that a distinction could be 
made between promoter occlusion (initiation suppression) and transcriptional collision 
(elongation suppression). The GAL10 and GAL7 genes were cloned opposite each other 
in a convergent orientation without a terminator between them. Secondly, to allow the 
measurement of transcription, two cassettes (resulting in G-less GAL10 RNA) were 
cloned into the plasmid - one short (105 bp), GAL10 ‘promoter-proximal cassette’, and 
another long (371 bp), ‘distal cassette’, inserted into the region between the GAL10 and 
GAL7 ORFs, approximately 2 kb downstream of the GAL10 promoter (Figure 4.1A). 
Finally, a control construct was created containing a mutated version of the GAL7  









Figure 4.1 Plasmids constructed to study collision in vivo. 
A. Schematic of the GAL10-GAL7 construct with short and long G-less cassettes displayed. B. 
GAL10-GAL7∆TATA construct with GAL7 promoter inactive. 
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promoter (GAL10-GAL7∆TATA) (Prescott and Proudfoot, 2002) to eliminate any 
transcription from GAL7 (Figure 4.1B). 
 G-less cassettes have been used in the past to study transcript elongation in vitro 
(Lee and Greenleaf, 1997, Sigurdsson et al., 2010) and here the same principles were 
applied to study RNAPII elongation in vivo. Yeast cells were grown in minimal media 
with raffinose, and then glucose (repressing the GAL genes) or galactose (activating the 
GAL genes) was added for 75 minutes prior to RNA extraction and RNase T1 digestion 
(Figure 4.2A). The RNase T1 specifically cleaves RNA after every G residue, 
degrading all transcripts but the 105 nt proximal, and 371 nt distal, G-less cassettes of 
the plasmid-borne GAL10 RNA. The products were then Northern blotted and detected 
using a radioactive probe directed against the G-less cassettes (Figure 4.2B). In the 
presence of glucose, no G-less RNA was produced, showing that the GAL genes used 
were indeed repressed, as expected (Figure 4.2B, lanes 1 and 2). However, following 
galactose-induced activation, products corresponding to the two G-less cassettes were 
observed (lanes 3 and 4, proximal and distal). Importantly, the level of distal cassette 
produced varied greatly between GAL10-GAL7∆TATA (in which there is no collision) 
and GAL10-GAL7, with the collision construct showing a reduction of distal cassette 
transcription by ~79% (compare lanes 3 and 4). However, the transcription of proximal 
cassette was largely similar in GAL10-GAL7∆TATA and GAL10-GAL7, indicating that 
changes in the level of distal cassette production were occurring at the level of 
elongation, not as a result of GAL10 initiation problems in the collision condition. This 
allows an important distinction to be made between transcriptional interference as a 
result of promoter occlusion and head-to-head collisions between actively transcribing  





Figure 4.2 Analysis of RNAPII convergent transcription in vivo. 
A. Schematic representing experimental layout. B. Northern blot showing RNA from GAL10-
GAL7∆TATA (-) (lanes 1 and 3) and GAL10-GAL7 (+) (lanes 3 and 4) isolated from strains 
induced with glucose (lanes 1 and 2) or galactose (lanes 3 and 4). Proximal and distal cassette 
signals are indicated as well as ‘% Distal Cassette Transcribed’ calculated by normalising to 
proximal cassette. Values presented are the mean with standard error (calculated from 2 
biological replicates) indicated below. 
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RNAPII ECs. Specifically, these results indicate that collisions are occurring in the ~2 
kb region between the G-less cassettes when both promoters are active. These results 
are in agreement with the biochemical data obtained (see Chapter 3) and suggest that 
RNAPII head-to-head collision is also a potent block to elongation in vivo. 
Additionally, these data confirm and expand upon observations seen in the Proudfoot 
laboratory (Prescott and Proudfoot, 2002), where run-on assays with GAL10-GAL7 
showed truncated transcripts being produced from both promoters. 
 The ability to localise RNAPII convergent collisions on a DNA construct 
formed a platform to study other aspects of this event. Importantly, knowing the 
location of high-frequency collision, chromatin immuno-precipitation (ChIP) could be 
performed to assess the fate of the collided ECs. 
4.3 Upon collision RNAPII is removed from DNA in a 
ubiquitylation-dependent manner 
 The potent block to transcript elongation observed upon convergent 
transcription in vivo suggested that cells do not efficiently deal with RNAPII head-to-
head collision, at least on the highly transcribed gene construct. Conceptually, it can be 
assumed that if two highly active promoters are driving transcription, polymerases 
would accumulate on the gene and the result would be an RNAPII ‘traffic jam’. In order 
to gain an insight into the events occurring at the interface of collision (specifically the 
fate of polymerases), RNAPII ChIP was employed. 
 Yeast containing the collision constructs were grown in liquid culture and 
transcription activated, prior to formaldehyde crosslinking, chromatin extraction, and 
sonication. ChIP was performed with the 4H8 antibody, directed against the C-terminal 
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domain of the largest RNAPII subunit, Rpb1, whilst non-specific ChIP using IgG was 
performed as the control (Figure 4.3A). Unexpectedly, instead of an increase in RNAPII 
levels in the region between convergent promoters in the GAL10-GAL7 collision 
construct (Figure 4.3B, lower, WT, white bar), the level was much reduced when 
compared to GAL10-GAL7∆TATA (WT, black bar). These data suggest RNAPII is 
removed following transcriptional collision. 
 Previous studies have shown that arrested RNAPII can be removed from DNA 
in a ubiquitylation-dependent manner. This is catalysed by recognition of arrested 
RNAPII, mono-ubiquitylation by Rsp5 and poly-ubiquitylation by the Elongin-Cullin 
complex in a Def1-dependent manner (see section 1.3.3.2). It was surmised that the 
ubiquitin-proteasome system could also play a role in the removal of arrested RNAPII 
from the convergent gene construct post-collision. In order to test this, ChIP was 
performed in two key mutants defective for RNAPII poly-ubiquitylation, namely elc1∆ 
and def1∆. In contrast to the decrease observed in WT cells, ChIP in elc1∆ cells showed 
a reproducible accumulation of RNAPII on the GAL10-GAL7 construct (Figure 4.3B, 
compare WT and elc1∆). A similar ChIP profile was observed in def1∆ cells (Figure 
4.3B, compare elc1∆ and def1∆). The accumulation of RNAPII in these two RNAPII 
ubiquitylation mutants argues strongly that this pathway is involved in RNAPII removal 
from the gene following transcriptional collision, in all likelihood through proteasome-
mediated degradation of the RNAPII subunit Rpb1. 
 Next it was important to determine if the accumulation of RNAPII, observed as 
a result of the inability to poly-ubiquitylate and degrade polymerases, had an affect on 
transcription in vivo. The G-less cassette constructs were used as a measure of transcript  






Figure 4.3 ChIP of RNAPII in WT cells and Rpb1 ubiquitylation mutants. 
A. Schematic showing procedure for performing ChIP. B.  Upper, diagram of the GAL genes 
showing the position of qPCR primers (black bar). Lower, qPCR analysis of 
immunoprecipitated DNA from WT, elc1∆ and def1∆ cells. Results normalised to GAL10-
GAL7∆TATA (=1). Error bars show standard error calculated from 3 biological replicates. 
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elongation in the presence of convergent transcription in WT and elc1∆ cells. The 
experiment was performed as before except that this time transcription was measured at 
various time points after induction. Surprisingly, there was little effect of deleting ELC1 
on transcript levels, though collision seems to shut down transcription of the distal 
cassette more rapidly, and may spread with time so that even the proximal cassette is 
relatively less transcribed in elc1∆ compared to WT (Figure 4.4A and B, compare the 
distal and proximal cassette transcription over time). However, these differences are 
surprisingly small. It is possible that the removal of collided polymerases by 
ubiquitylation/degradation in WT cells is not rapid enough to keep up with the high 
initiation rate and collision on this construct. 
 The notion that ubiquitylation might have a role in bypass is an interesting one 
and had actually already been tested in vitro using the biochemical scaffold system, 
prior to the in vivo observation. Although this chapter is focussed on in vivo work, this 
seems an appropriate place to present those findings. The two documented 
ubiquitylation sites of RNAPII are Rpb1 K330 (Figure 4.5A) and K695 (Figure 4.5B), 
with K330 located surprisingly close to the RNAPII active centre in a position that 
might potentially alter DNA conformation, or the interaction of Rpb1 with the NTS 
(Figure 4.5A). To determine if ubiquitylation directly stimulates transcriptional bypass, 
mono- and di-ECs were reconstituted and ubiquitylated in vitro using highly purified E1 
(Uba1), E2 (Ubc5), E3 (Rsp5) and lysine-free ubiquitin, to allow only mono-
ubiquitylation of Rpb1 (Figure 4.6A). Otherwise, Rsp5 generates (non-physiological) 
K63-chains on RNAPII in vitro, and it was surmised that if RNAPII ubiquitylation 
played a role in elongation then the presence of a bulky ubiquitin moiety would be 
sufficient to show an effect. Di-ECs were efficiently ubiquitylated prior to transcription,  




Figure 4.4 An analysis of transcription in WT and elc1∆ cells. 
A. Northern blot of RNA isolated from WT (lanes 1-6) or elc1∆ (lanes 7-12) cells containing 
GAL10-GAL7∆TATA (-) or GAL10-GAL7 (+) 30, 60, or 120 minutes after galactose induction. 
Proximal and distal cassette are indicated (right). B. A biological replicate of A. 







Figure 4.5 RNAPII structure with highlighted ubiquitylation sites. 
A. Crystal structure of an RNAPII-EC (from above) with Rpb1 K330 highlighted (yellow). TS 
(cyan), NTS (green) and RNA (red) are also shown. B. RNAPII-EC structure (from underneath) 
with K695 highlighted (red). The RNAPII pore can be identified (centre) by the DNA and RNA 
being visible through it. 






Figure 4.6 Ubiquitylation of ECs. 
A. Experimental schematic. B. Western blot against Rpb1 (4H8 antibody) of di-ECs used in C 
prior to initiating transcription. Rpb1 and ubiquitylated Rpb1 indicated, right. C. Transcription 
analysis of mono- (M) and di-ECs (D) non-ubiquitylated (-) or ubiquitylated (+) prior to 
transcription with AUC (lanes 1-4) or AUCG (lanes 5-8). 
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with the vast majority of Rpb1 being ubiquitylated at one or more sites, as expected (see 
mobility shifts in Figure 4.6B). Transcription was initiated via the addition of a 
selection of NTPs (AUC), (Figure 4.6C, lanes 1-4) or all NTPs (AUCG) (Figure 4.6C, 
lanes 5-8), and RNA isolated. As these elongation complexes were un-purified, a 
certain percentage of mono-EC contamination was present in the reaction, resulting in 
some full-length RNA production. However, the level of full-length RNA did not 
change significantly during transcription with ubiquitylated di-ECs, nor did the level of 
the different truncated RNAs decrease (compare lanes 3 and 4 and lanes 7 and 8). These 
data show that, somewhat surprisingly, RNAPII ubiquitylation does not significantly 
affect transcription. More specifically, it also fails to induce transcriptional bypass. 
These data add further support to the assertion that ubiquitylation-dependent removal of 
RNAPII from the GAL10-GAL7 gene in vivo is a result of proteasome-mediated 
degradation, rather than ubiquitylation-mediated bypass. 
4.4 RNAPII collision intermediates are stabilised in an elc1∆ 
mutant 
 To further characterise the post-collision role of Elc1, an experiment was 
designed to study the rate of RNAPII removal from DNA. The addition of glucose to 
cells results in the rapid shutdown of transcription from GAL genes and has been 
extensively characterised (Mason and Struhl, 2005). Therefore, this could be used to 
determine the rate of RNAPII removal from GAL10-GAL7 compared to the internal 
control GAL1 (GAL1 is co-regulated with GAL10 at the endogenous locus and therefore 
provides an ideal control for normal transcriptional shutdown and RNAPII 
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disappearance). It was surmised that collided RNAPII should have a longer half-life 
than regularly transcribing and terminating RNAPII, especially in an elc1∆ mutant. 
 Analysis of RNAPII occupancy on the GAL1 gene (Figure 4.7A) shows a 
significant, rapid shutdown of transcription upon glucose addition, with minimal levels 
of RNAPII remaining on the gene after 6 minutes. At this gene, both WT and elc1∆ 
show similar repression kinetics, with only a slight initial delay in elc1∆. However, 
even in WT cells, RNAPII occupancy on the GAL10-GAL7 collision construct did not 
decrease as rapidly as seen at the GAL1 control, with ~50% RNAPII remaining even 
after 6 minutes (Figure 4.7B, black bars). This difference was even more pronounced in 
elc1∆, which showed an increase in the level of RNAPII arrested at GAL10-GAL7, 
which stabilised at ~80% RNAPII following 6 minutes of repression (Figure 4.7B, grey 
bars). These data show that, not surprisingly, the rate of RNAPII removal from a gene is 
similar in WT and elc1∆ when collision is absent. However, in the presence of head-to-
head collision, arrested ECs require poly-ubiquitylation and degradation in order to be 
removed from the gene, with collision intermediates stabilised in the ubiquitylation-
deficient elc1∆ mutant. 




Figure 4.7 Timecourse of RNAPII occupancy on endogenous GAL1 or GAL10-GAL7 
collision construct. 
A. Upper, diagram of endogenous GAL1 (no-collision control) showing the position of the 
qPCR product (black bar). Lower, RNAPII occupancy following transcriptional shutdown (time 
after, indicated) in WT or elc1∆ cells. Values normalised to 0  minute timepoint (=100%). Error 
bars are standard error from 3 biological replicates. B. As in A but for GAL10-GAL7 collision 
construct. 
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4.5 RNAPII accumulates between natural convergent genes in 
an elc1∆ mutant 
 In an elc1∆ mutant, the inability to poly-ubiquitylate and degrade RNAPII 
means that the usually short-lived post-collision intermediates are stabilised. As 
mentioned previously, RNAPII head-to-head collisions are likely to be stochastically 
distributed under normal circumstances, making their detection difficult. However, the 
increased stability, and likely accumulation, of collided complexes in an elc1∆ strain 
raised the possibility of observing collision at natural genes. It is important to study this 
at natural genes expressed at endogenous levels, as arguably, the convergent gene 
construct used in the previous experiments does not properly represent the true in vivo 
situation, being highly expressed and engineered for the purpose of promoting RNAPII 
collision. Additionally, detection of collided RNAPII at endogenous loci would provide 
support for this phenomenon occurring in cells. 
 A genome-wide approach was employed to study collided RNAPII on 
endogenous genes in both WT and in an elc1∆ mutant. ChIP of RNAPII was performed 
under highly stringent conditions, again using the CTD-specific antibody 4H8, or IgG 
as a control. The ChIP was efficient and highly specific for Rpb1 of RNAPII across 
both cell types and between replicates (Figure 4.8, compare lanes 3 and 5). ChIP 
specificity is of even greater importance in genome-wide studies, where relatively low 
levels of DNA need to be detected. The presence of false ChIP signals can thus lead to 
masking of true occupancy signals and generation of false positives. 
 The DNA from the immuno-precipitated samples was subjected to library 
preparation at the CRUK-LRI Advanced Sequencing Facility, and sequenced using a 
GAII-x Illumina sequencer and standard protocols. Bioinformatic analysis of the data  








Figure 4.8 Western blot of RNAPII immuno-precipitation. 
Western blots from two WT and elc1∆ replicate ChIPs probed with anti-Rpb1 antibody (4H8). 
RNAPII levels for Input (IN), flow-through (FT) and immuno-precipitated sample (IP) 
following RNAPII or IgG (control) chromatin immuno-precipitation are presented. 
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was performed in collaboration with Wu Wei and Lars Steinmetz (Genome Biology 
Unit, EMBL). The sequencing reads obtained were filtered and aligned to the S. 
cerevisiae genome before subtraction of the IgG control signal and grouping of genes 
into convergent, divergent, or tandem pairs (see section 2.10). Finally, intergenic 
RNAPII density (averaged from two biological replicates) was calculated across all 
gene pairs.  
 If collisions do indeed occur between polymerases transcribing natural genes, it 
is expected that these would most likely be observable at convergent genes in elc1∆ 
cells (Figure 4.9A, schematic). Remarkably, although there was no significant 
difference in RNAPII density inside the coding regions of genes, a clear increase was 
indeed observed in the region between convergent genes in the elc1∆ mutant (Figure 
4.9A). Importantly, when a similar analysis was performed between divergent genes 
(Figure 4.9B, schematic), which are orientated away from one another and represent 
areas of low collision probability, RNAPII density is similar between WT and elc1∆ 
(Figure 4.9B). This shows that the elc1∆ RNAPII peaks are specific to 3’ ends of 
convergent gene pairs, where collision is most likely to occur. 
 A difficulty arises when interpreting data concerning RNAPII head-to-head 
collisions on natural genes. This is due to the frequent, pervasive and randomly 
distributed nature of non-coding transcription. Additionally, many promoters are bi-
directional, and antisense transcripts are also commonly synthesised from the 3’ end of 
genes (Xu et al., 2009, Neil et al., 2009, Katayama et al., 2005). Therefore, divergent 
gene pairs are the only good example of a negative control, as collisions are also likely 
to occur at, for example, the promoter-proximal and 3’ regions of tandem gene pairs 
(Figure 4.10A, schematic). In support of this, when RNAPII density was analysed at  




Figure 4.9 RNAPII occupancy on convergent and divergent gene pairs. 
A. Upper, schematic representing regions of analysis. Lower, ChIP-Seq data from WT (blue) 
and elc1∆ cells (red) showing RNAPII occupancy at the mid-point between convergent genes. 
Data plotted is the average of two biological replicates. B. As in A but data plotted for all 
divergent genes. 
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tandem gene pairs, RNAPII accumulated in the 3’ intergenic region between the end of 
one ORF and the promoter of the downstream gene in elc1∆, but not in WT cells 
(Figure 4.10 A). The increased RNAPII density in elc1∆ cells was, however, not as 
dramatic as for convergent genes (compare with Figure 4.9A), which are likely sites of 
more frequent head-to-head collisions. Additionally, when tandem gene pairs separated 
by greater intergenic distances (<600 bp but >400 bp) were analysed specifically, the 
RNAPII peak observed in elc1∆ cells resolved into two distinct peaks (Figure 4.10B, 
upper). There was not a similar peak distribution of RNAPII in WT cells (Figure 4.10B, 
upper, compare blue and red lines) and the peaks could not be resolved when genes 
separated by short intergenic distances were analysed (Figure 4.10B, lower). The two 
peaks seen at these tandem gene pairs suggest that there are two separate populations of 
RNAPII arrested in the intergenic region. It is tempting to interpret these as separate 
collision events; one occurring between sense- and antisense-transcribing polymerases 
at the 3’ end of the first gene, and another between polymerases firing from the bi-
directional promoter of the downstream gene and those terminating from the upstream 
gene (Figure 4.11). The overall probability of these collisions is likely lower than that 
expected at convergent genes, and the ChIP signal supports this. 
 Another possible explanation for the accumulation observed at both tandem and 
convergent gene pairs is that deletion of ELC1 causes RNAPII termination defects 
(although the gene has never previously been implicated in this process), so to address 
this possibility RNA-Seq was performed. Here, it was surmised that general read-
through of terminators would be observable as longer RNAs in elc1∆. Total RNA was 
extracted from WT and elc1∆ cells grown to mid-log phase in YPD. Extracted RNA 
was RiboZero treated to remove rRNA, but poly-A selection was not performed, to  




Figure 4.10 RNAPII occupancy on tandem genes. 
A. Upper, schematic representing region of analysis. Lower, ChIP-Seq data plotted at the 
intergenic region between tandem gene pairs in WT (blue) and elc1∆ (red). B. Filtered ChIP-
Seq data showing tandem pairs separated by >400 bp but <600 bp with peaks indicated (upper) 
and <400 bp only (lower). Note that WT is red and elc1∆ blue in this plot. 
 










Figure 4.11 Schematic representation of collision at tandem genes. 
Upper, schematic representing RNAPII collisions between gene-initiated RNAPII and a 3’ 
antisense-transcribing polymerase (left), or with RNAPII initiated from a bi-directional 
promoter (right). Sense (gene) promoters represented by solid arrow, dashed arrow represents 
antisense promoter. Lower, representation of ChIP signal in Figure 4.10B. 
 
Chapter 4 Results 
 
 156 
prevent a bias towards mRNA. As before, the RNA was sequenced using the GaIIx 
Illumina platform and reads aligned to the S. cerevisiae genome; bioinformatics was 
again performed in collaboration with Wu Wei and Lars Steinmetz. As before, genes 
were classified into three groups dependent upon their orientation and the reads at the 3’ 
end of the gene and intergenic region plotted. At both tandem (Figure 4.12A) and 
convergent (Figure 4.12B) gene pairs, the RNA levels were practically identical in WT 
and elc1∆ cells (compare blue and red lines). This argues against a termination defect in 
elc1∆ mutants, which would be expected to manifest itself as an accumulation of 
transcripts at the 3’ end of genes.  
 The data presented in this section show that RNAPII accumulates in an elc1∆ 
mutant specifically in regions where head-to-head collisions are expected to occur. WT 
cells do not display similar patterns of RNAPII build-up, suggesting that in the presence 
of a fully functioning ubiquitin-proteasome system collided polymerases are efficiently 
removed. The presence of the Elongin-Cullin pathway indicates why cells tolerate 
potent, gene-blocking RNAPII collision. 
 





Figure 4.12 RNA-Seq data from WT and elc1∆ cells. 
A. RNA-Seq data from WT and elc1∆ cells represented relative to the end of tandem genes 
(distance indicated in bp). Data shown is an average of three biological replicates. B.  As in A 
but for convergent genes. 
  




 The data presented in this chapter address the physiological relevance and nature 
of RNAPII head-to-head collision in vivo. A highly controllable transcription template 
was created, allowing head-to-head collisions to be induced at a specific, observable 
region on DNA. Data obtained show that the presence of a convergently transcribing 
RNAPII molecule represents an insurmountable obstacle to transcription in vivo. This is 
in support of the data obtained in vitro (see Chapter 3), which showed that RNAPII 
molecules stop following head-to-head collision and are unable to bypass one another. 
In stark contrast to the in vitro scaffold system (where accessory factors are absent and 
RNAPII remains firmly bound to the DNA template after collision), RNAPII is 
removed from the convergent gene construct following head-to-head collision. This was 
discovered to result, at least partly, from the activity of the RNAPII ubiquitylation 
machinery. This pathway is responsible for the poly-ubiquitylation and degradation of 
Rpb1 following irreversible arrest by RNAPII, as polymerase removal was severely 
compromised in two key mutants of this pathway, elc1∆ and def1∆. Interestingly, 
however, abolishing poly-ubiquitylation had little effect on overall transcription levels 
from the collision construct in vivo, and ubiquitylation of di-ECs had no direct effect on 
convergent transcription in vitro. Possibly, GAL-GAL transcription results in levels of 
collision that overload the ubiquitylation system. In any case, these observations lend 
further support to a degradation-related role of poly-ubiquitylation following 
transcriptional collision, rather than a direct mechanistic effect on transcription. 
 The decrease in RNAPII degradation upon collision in elc1∆ cells led to an 
accumulation of collided polymerases on the convergent gene construct. As a result of 
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this, RNAPII collisions could be studied in their physiological setting at natural genes. 
This analysis was important, as the convergent gene construct was highly expressed and 
arguably not fully representative of the true physiological scenario. However, the 
genome-wide analysis strongly supports the idea that RNAPII collisions do indeed 
occur in vivo, as RNAPII was shown to accumulate at regions where collision was 
likely, in an elc1∆ mutant but not in WT cells. These data are a further indication of the 
physiological relevance of RNAPII head-to-head collisions in vivo. It seems that 
collisions are fairly common (but stochastically distributed) and dealt with by poly-
ubiquitylation and degradation. Arguably, collision could have a role in regulation of 
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Chapter 5. Discussion 
 There is a plethora of genome-wide data showing that transcription is 
surprisingly pervasive in cells (see section 1.5.2). Furthermore, antisense transcription 
often initiates from 3’ ends of genes and NFRs, and is commonly concurrent with 
transcription of protein-coding genes (Xu et al., 2009, Neil et al., 2009, Vallon-
Christersson et al., 2007). In conjunction with this, genes are arranged into pairs that 
can affect one another’s regulation (see section 1.5.1). Thus, the transcriptional 
landscape is far more complex than previously envisaged, with the poorly understood 
element of gene-, and specifically RNAPII-traffic, playing an important role in gene 
expression. Several studies highlight this importance, showing the act of transcribing 
ncRNA to have a role in the repression, or activation of genes (Martens et al., 2004, 
Hongay et al., 2006, Uhler et al., 2007). Additionally, studies addressing the act of 
tandem (sense) transcription by multiple RNAPII molecules, have provided an insight 
into this process and especially its ability to aid RNAPII processivity during elongation 
(Saeki and Svejstrup, 2009, Jin et al., 2010). However, there is a distinct lack of 
knowledge regarding the fundamental nature of convergent transcription. The main aim 
of this thesis was to address this shortfall and answer the absolutely fundamental 
question: can RNAPII molecules transcribe past one another? The data contained, 
herein, show that both in a basic biochemical assay and in vivo, RNAPII molecules 
cannot transcribe past one another, in fact they represent insurmountable obstacles to 
further elongation. They stop upon touching, remaining stably bound to the DNA 
template. Additionally, data obtained in this thesis provide evidence that these collisions 
do occur in vivo, where the collided polymerases are substrates for poly-ubiquitylation 
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and degradation. In all likelihood, collision is rare at any individual site, but very 
frequent across the genome. 
 It might be expected that colliding polymerases, resulting from convergent 
transcription, could dissociate one another from the DNA template. However, ECs are 
remarkably stable, with the finding that even head-to-tail RNAPII collision does not 
lead to dissociation providing further evidence for this (Saeki and Svejstrup, 2009). 
Although the frequency of RNAPII collision is unclear, when it does happen this results 
in RNAPII arrest and a block to elongation, which needs to be dealt with. Indeed, 
polymerases arrested as a result of other circumstances, such as DNA damage, need to 
be removed because transcriptional arrest blocks gene transcription and can affect other 
DNA metabolic events (Sigurdsson et al., 2010, Svejstrup, 2003, Svejstrup, 2007a). The 
findings of this thesis lend support to the theory that all irreversibly stalled RNAPII 
molecules are likely to be dealt with by poly-ubiquitylation and degradation as a last 
resort. This process is reliant upon Rpb1 mono-ubiquitylation by Rsp5, followed by 
Elongin-Cullin-mediated poly-ubiquitylation (occurring in a Def1-dependent manner) 
and proteasome-mediated degradation (see section 1.3.3.2).  
 The finding that polymerases stop upon head-to-head collision and are unable to 
invade one another’s space was surprising. Furthermore, this is in stark contrast to 
RNAPII-nucleosome interactions, where DNA is ‘stripped’ off the surface of the 
nucleosome by the transcribing polymerase, or head-to-tail (tandem) RNAPII collisions, 
where temporary, but extensive, structural intermingling was observed (Studitsky et al., 
1995, Kireeva et al., 2005, Saeki and Svejstrup, 2009). This shows that the nature of 
RNAPII head-to-head collision could differ fundamentally from head-to-tail collision. 
There were two models suggested for the structural invasion and ‘recoil’ of RNAPII 
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upon head-to-tail collision. The first, is that invasion is mediated by changes in RNAPII 
protein conformation, implicating mobile domains in the polymerase structure, such as 
the jaw lobe and clamp (Saeki and Svejstrup, 2009). Additionally, the ability of 
polymerase to swivel/rotate on DNA (Herbert et al., 2008) could facilitate this invasion. 
The protein domains that interact upon head-to-tail collision are of very different shapes 
and topology. It is, therefore, possible that the protein density of the leading polymerase 
acts as a ‘wedge’, separating the mobile domains of the trailing polymerase, allowing 
invasion. In contrast, during head-to-head collision, the protein domains that interact are 
very similar and may be unable to separate the mobile domains, thus explaining the lack 
of invasion. The second model proposed, was that changes in DNA topology account 
for the perceived protein intermingling. It is possible that the DNA helix between the 
two transcription bubbles could unwind, or stretch, allowing the trailing polymerase to 
continue transcribing and for its footprint to decrease, whilst not actually invading the 
space of the leading polymerase. Furthermore, the change in DNA topology could 
provide the energy to drive backtracking of the trailing polymerase.  
 During transcription, the DNA topology changes as RNAPII will generate 
positive supercoils in front of, and negative supercoils behind, itself (Liu and Wang, 
1987, Osborne and Guarente, 1988). In the case of convergent transcription positive 
supercoiling would thus be expected to accumulate between the polymerases, whilst 
negative and positive supercoiling would cancel out during tandem transcription. Indeed, 
accumulation of supercoiling has been shown to drastically reduce the efficiency of 
convergent transcription in the absence of DNA topoisomerases (Garcia-Rubio and 
Aguilera, 2011). Supercoiling effects are not an issue in the in vitro system used here, as 
the DNA template has free ends, which can rotate to counteract torsional strain. 
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Therefore, the inhibition of transcription in the di-EC reaction cannot be accounted for 
by a build up of torsional strain. Moreover, as mentioned above, DNA topoisomerases 
efficiently deal with supercoiling arising during transcription in vivo (Liu and Wang, 
1987, Garcia-Rubio and Aguilera, 2011). 
 The creation of a convergent gene construct with which head-to-head RNAPII 
collision could be induced at a specific, examinable locus, provided evidence for 
polymerase collisions in vivo. This system was, however, used simply as a tool to gain 
more understanding of the process, as arguably, the high transcription levels at these 
convergent units are probably not physiological. However, one of the key findings of 
this system was that the Elongin-Cullin complex and Def1 have a role in removing 
RNAPII from DNA following head-to-head collision. In a more general confirmation of 
this, on a genome-wide scale RNAPII accumulated between natural convergent gene 
pairs in an elc1∆ mutant.  
 Although evidence has been obtained for a role of elc1∆ and the ubiquitin-
proteasome system in removing collided RNAPII from DNA, it is likely that alternative 
mechanisms do exist. In support of this, ELC1 and DEF1 are not required for cell 
viability. It is an intriguing possibility that an RNAPII bypass factor(s) does exist in 
vivo. An enzyme with helicase/translocase activity would be the most likely candidate. 
Alternatively, there could be factors that act to dissociate collided ECs following 
collision. The Rho termination factor (in bacteria) as well as Rat1 and Sen1 (in yeast) 
have all been implicated in EC destabilisation (see section 1.4). In addition to these 
characterised factors, a yeast factor similar to TTF2 (transcription termination factor 2), 
a protein in humans which causes EC destabilisation in an ATP-dependent manner (Xie 
and Price, 1996), might be involved in the process. Such activities might act in a 
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redundant fashion, with poly-ubiquitylation being a last-resort pathway for coping with 
collided polymerases. In the experiments presented here, it is likely that any resolution 
of collision made possible by a bypass/dissociation factor was masked by the high 
expression levels of the GAL collision construct. It was unfortunate that no conclusive 
evidence for the existence of a bypass factor could be found in the crude extract. The 
difficulty of producing and purifying a large amount of di-ECs, however, means that it 
is not a readily amenable substrate for use in biochemical fractionation experiments. For 
this to be possible, it would be advantageous to set up a new, simpler assay. One 
possibility is to create a genetic construct to screen for bypass factors in vivo. A method 
for doing this would be to take two genes associated with amino acid biosynthesis, for 
example HIS3 and TRP1, and clone them in a convergent orientation into a plasmid, 
with no terminators separating them. Presumably, such a gene organisation would 
negatively effect expression of both marker genes, which would in theory provide a 
convenient way of identifying bypass factors, by transforming this construct into the 
yeast genetic deletion library and screening for survival on selective plates. 
5.1 A role for transcriptional collision in gene regulation 
 The complex interaction between sense and antisense transcription is likely to 
play an important role in fine-tuning gene expression. In support of this, recent data 
indicate that genes with antisense transcripts running across them show increased 
expression level variability (Xu et al., 2011). This means that when activated they show 
rapid and high expression, whereas when in a repressed state these genes exhibit 
remarkably low levels of expression. It is very likely that in the sense-antisense gene 
pairs characterised by high expression levels, the act of transcribing the antisense RNA 
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helps maintain an open chromatin structure at the promoter and a favourable 
environment for rapid initiation. Indeed, this has been shown to be the case at the PHO5 
gene (Uhler et al., 2007). Conversely, in genes characterised by extremely tight 
repression, such as IME4, which commits a cell to meiosis (Hongay et al., 2006), this 
could be mediated by two main effects: promoter occlusion and RNAPII head-to-head 
collision during elongation.  
 The findings of this thesis suggest a model in which the tight repression of non-
activated genes with an antisense transcript running across them could occur. When in a 
repressed state, the antisense transcript originating from the 3’-end of the ORF 
transcribes across the coding region and promoter of the gene (Figure 5.1, (1)). 
However, if unscheduled initiation does occur at the gene (sense) promoter and RNAPII 
manages to enter into the processive elongation phase, it would likely collide with 
antisense-directed RNAPII (Figure 5.1, (2), upper). The subsequent collision would lead 
to Elongin-Cullin-mediated poly-ubiquitylation and degradation of the polymerases, 
freeing up DNA so that antisense transcription could resume (Figure 5.1, (2), lower). 
Destruction of the sense polymerase and its nascent RNA would be highly 
advantageous if its translation were detrimental for the cell. The method of repression 
by antisense-transcribing RNAPII is likely to be two-fold; apart from the repression 
through collision, it likely also displaces transcription factors from the gene promoter, 
helping eliminate subsequent rounds of unscheduled transcription (Figure 5.1, (3)). 
 Some studies have found that when the sense gene is activated, the levels of 
antisense RNA produced decrease to an undetectable level (Hongay et al., 2006, Uhler 
et al., 2007). This suggests that under activating conditions (Figure 5.2, (1)) the gene 
promoter is highly dominant and can overcome the repression imposed by RNAPII  




Figure 5.1 The interactions between sense-antisense transcription during sense gene 
repression. 
Low levels of antisense transcription occur during repression of the sense gene (1), however, 
non-activated unscheduled initiation sometimes occurs, leading to head-to-head collision 
between the sense- and antisense-directed polymerases, which are both poly-ubiquitylated and 
degraded (2). Subsequent re-initiation occurs at the antisense promoter leading to transcription 
across the sense promoter and displacement of transcription factors (3). 
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collision and promoter occlusion. There is still likely to be collision on such genes, 
however, at least during early activation where the pioneering RNAPII molecule would 
meet the antisense-transcribing polymerase (Figure 5.2, (2)). This event, as in the case 
of unscheduled transcription from a repressed promoter, would likely also lead to poly-
ubiquitylation and degradation of the polymerases. However, activated transcription is 
characterised by high levels of re-initiation. Therefore, it is likely that multiple RNAPII 
molecules ‘stack-up’ behind the pioneering polymerase and, following its degradation, 
keep transcribing downstream, eventually occluding the antisense promoter leading to 
its repression (Figure 5.2, (3)). Although the model provided is speculative, it is 
consistent with the data presented in this thesis and would also help explain the 
genome-wide expression data for sense-antisense pairs (Xu et al., 2011). 
 In conclusion, the emerging view from numerous genome-wide studies is that 
RNAPII constantly and stochastically initiates across the genome, often producing 
antisense ncRNA (Xu et al., 2009, Neil et al., 2009, Vallon-Christersson et al., 2007, He 
et al., 2008, Katayama et al., 2005). The transcriptional landscape is thus extremely 
complex, and RNAPII traffic must have an effect on gene expression and regulation. 
Through several recent studies and the data presented in this thesis, the complexity of 
gene traffic is beginning to be understood (Saeki and Svejstrup, 2009, Jin et al., 2010). 
In all likelihood, such collisions are rare at any individual site, but very frequent across 
the genome. The occurrence of head-to-head collision and the ensuing RNAPII arrest, 
presents the cell with a situation that must be resolved. The data presented in this thesis 
provide a basis for an understanding of RNAPII head-to-head collision and its role in 
gene expression. 




Figure 5.2 The interactions between sense-antisense transcription during sense gene 
activation. 
Activated transcription at the sense gene results in sense transcription and collision with 
antisense-directed RNAPII (1). The antisense-directed polymerase and the pioneering sense 
RNAPII are poly-ubiquitylated and degraded, whilst frequent re-initiation is occurring upstream 
at the sense promoter (2). A substantially greater number of sense-transcribing RNAPII 
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